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1029-237 Role of B-Type Natriuretic Peptide for the Monitoring of 
Anthracycline-Induced Cardiotoxicity
Sanjeev Sanjeev, Michael Pettersen, Joellyn Gurczynski, Kanta Bhambani, Thomas J. 
L’Ecuyer, Children’s Hospital of Michigan, Detroit, MI
Background: The major limitation of the anthracyclines (AC) class of cancer 
chemotherapeutic drugs is progressive cardiotoxicity. Currently, patients receiving AC 
are monitored by echocardiographic measurement of shortening fraction (SF). Other 
indices, though more sensitive, are technically difﬁcult to obtain. There is a need for a 
sensitive and rapid biomarker to detect cardiac injury in these patients. B-type natriuretic 
peptide (BNP) is a hormone secreted from the ventricles in response to hemodynamic 
stress. BNP is an objective bedside test that accurately detects asymptomatic cardiac 
dysfunction and correlates with the severity of congestive heart failure in adults. The 
purpose of the study is to determine the correlation between plasma BNP and cardiac 
function on echocardiogram in patients treated with AC.
Material and methods: Sixty-three patients (pts) treated with AC chemotherapy atleast 1 
year prior to enrolment were included. All patients underwent a detailed echocardiogram 
[including SF, rate corrected velocity of circumferential ﬁber shortening (VCFc), end 
systolic wall stress (ESWS), the relationship between the two (VCFc: ESWS) and diastolic 
parameters such as mitral inﬂow velocities (E/A ratio) and isovolumic relaxation time] and 
simultaneous plasma BNP level.
Results: The cohort included 37 males with the mean age of 13.7 yrs (range, 6.5-26.5 
yrs). Cancer was diagnosed at a mean age of 7.7 years (range, 1m- 20.5 yrs) and the 
mean duration of follow up was 5.2 yrs (range, 1-18.5 yrs). Cardiac dysfunction deﬁned as 
any one of the following: SF<29%, VCFc60g/cm2, an abnormal VCFc: ESWS or abnormal 
diastolic indices compared to established age speciﬁc norms was found in 24 (38%) pts. 
Nine of the 63 (14%) pts had abnormal SF alone. Plasma BNP in pts with abnormal 
cardiac function (n=24) are signiﬁcantly higher than the normal pts(n=39) (24.3 ± 5.3 vs. 
14.1 ±1.4, p<0.05). Plasma BNP is inversely proportional to SF (p=0.008).
Conclusions: A third of patients who have received AC have an abnormality in cardiac 
function on detailed echocardiogram. Plasma BNP is a useful bedside screening test that 
is signiﬁcantly increased in patients with abnormal cardiac function.
1029-238 B-Type Natriuretic Peptide: A Bedside Biomarker of 
Hemodynamically Signiﬁcant Patent Ductus Arteriosus
Sanjeev Sanjeev, Michael Pettersen, Jorge Lua, Seetha Shankaran, Thomas J. L’Ecuyer, 
Children’s Hospital of Michigan, Detroit, MI
BACKGROUND: A hemodynamically signiﬁcant patent ductus arteriosus (hsPDA) has 
important clinical consequences in preterm neonates. Although accurately diagnosed by 
an echocardiogram (echo), there is a need for a sensitive, inexpensive, easily performed 
diagnostic test in patients suspected to have hsPDA. B type natriuretic peptide (BNP) 
is a hormone secreted by the ventricles under hemodynamic stress. The objective of 
the present study is to evaluate whether BNP can be used as a screening test for the 
presence of a hsPDA in the preterm neonate.
MATERIAL AND METHODS: This was a prospective study involving preterm neonates 
with birth weights ≤1500 grams and gestational age ≤34 weeks in whom an echo was 
performed for clinical suspicion of PDA. Newborns with congenital cardiac defects and 
conditions known to increase BNP levels were excluded. Patients underwent a repeat 
echo 48 - 72 hours later or 48-72 hrs after completion of treatment, if hsPDA present. 
hsPDA was deﬁned by ≥ 2 of the following echo parameters: left atrial to aortic root ratio 
>1.4:1, left ventricle to aortic root ratio > 2.1:1 and ductal diameter > 1.5 mm. BNP assay 
was performed within 3 hours of each echo by Triage BNP system. Data were expressed 
as mean ± SEM, signiﬁcant p< 0.05.
RESULTS: Twenty-nine newborns with a median weight of 870 grams (560-1325 g) and a 
median gestation 26 weeks (24 -31 weeks) were enrolled. At a median age of 7 days (2-
28 days), BNP levels were signiﬁcantly higher in neonates with hsPDA (n=19) compared 
to those without (n=46), (453.6 ± 123.9 pg/ml vs. 37.4± 6.6 pg/ml p<0.0001). At a cut off 
value of 70 pg/ml, BNP had a sensitivity of 94.7%, speciﬁcity of 89%, positive predictive 
value of 78.2% and negative predictive value of 97.6% for detection of hsPDA. BNP levels 
dropped signiﬁcantly after medical or surgical closure of hsPDA (n=12), (404.9 ± 159.2 
pg/ml to 25.1 ± 4.1 pg/ml, p = 0.03).
CONCLUSIONS: Elevation of plasma BNP accurately detects the presence of hsPDA 
in premature infants. Changes in BNP with treatment reﬂect whether therapy has been 
successful. A BNP cutoff of 70pg/ml is a useful screening tool for diagnosis and treatment 
of hsPDA that may improve clinical care and decrease the cost of health care in preterm 
babies.
1029-239 Initial Experience With Nesiritide in Pediatric Heart 
Failure
William T. Mahle, Angel Cuadrado, Paul M. Kirshbom, Kirk R. Kanter, Janet M. Simsic, 
Children’s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA
Nesiritide has been shown to be effective in the management of acute decompensated 
heart failure in adults. The role of Nesiritide in pediatric heart failure has not been 
examined. The current study represents a pilot investigation to deﬁne the safety and 
cardiorenal effects in children admitted to the cardiac intensive care unit with heart failure. 
Nesiritide was administered in an open-label fashion to patients (pts) with heart failure who 
were already receiving inotropic and diuretic therapy. Between 7/1/03 and 8/1/04, 38 pts 
ages 5 days to 16.7 years (median age: 9.0 mos) received Nesiritide therapy. Diagnoses 
of those receiving Nesiritide therapy included: single ventricle congenital defect (n=6), 
two-ventricle congenital defect (n=19), transplant (n=5), and dilated cardiomyopathy 
(n=8). Nineteen pts were started on Nesiritide within 2 weeks of corrective or palliative 
heart surgery. An initial bolus dose of 1 mcg/kg was administered followed by continuous 
infusion of 0.005-0.02 mcg/kg/min. Nesiritide was discontinued for possible side-effects 
in 2 pts (arrhythmia & hypotension). Duration of therapy ranged from 1-32 days (median, 
4.5 days). Hemodynamic measurements just prior to Nesiritide and 24 hrs later are 
shown (table). Conclusions: Nesiritide is well tolerated in children with heart failure and 
is associated with improved diuresis and natriuresis. Further prospective studies will be 
needed to compare Nesiritide with other vasoactive agents and examine the cost-efﬁcacy 
of this therapy.
Hemodynamic and Renal Function Pre- & Post- Nesiritide 
PRE POST P
Systolic BP (mmHg) 90.6±19.2 83.3±16.5 0.13
Diastolic BP (mmHg) 49.51±2.3 46.2±12.0 0.30
CVP (mmHG)(n=24) 11.7±4.1 9.2±4.3 0.02
24 hr Fluid balance (cc/kg/hr) +0.76 -0.44 0.04
1029-240 A Prospective Evaluation of Intravenous Nesiritide in 
Pediatric Heart Failure
John L. Jefferies, Susan W. Denﬁeld, William J. Dreyer, Jack F. Price, Jeffrey J. Kim, 
Vivian V. Dimas, Sara Clunie, E. O’Brian Smith, Colin J. McMahon, Tiffany I. Wann, 
Brady S. Moffett, Jeffrey A. Towbin, Baylor College of Medicine, Houston, TX
Background: The recombinant brain-type natriuretic peptide Nesiritide has become 
widely used and effective in the treatment of decompensated heart failure (HF) in adults. 
Limited data on safety and efﬁcacy in the management of HF in children exists. We 
speculated that decompensated HF in patients under age18 regardless of etiology could 
be safely and effectively managed using Nesiritide.
Methods: We prospectively evaluated 47 separate infusions of Nesiritide in 26 individual 
patients. All patients underwent induction and titration of therapy in an ICU setting. No 
bolus dose was given. All patients started at a dose of 0.01 mcg/kg/min and titrated at the 
discretion of the investigators to a maximum dose of 0.03 mcg/kg/min in escalating doses 
of 0.005 mcg/kg/min. All patients underwent monitoring of hemodynamics, urine output, 
electrolytes, oxygen requirements, oral intake, and functional status as assessed by the 
patients and/or their parents. In selected patients, pre and post infusion aldosterone levels 
were measured.
Results: All patients successfully underwent inititiation/titration of Nesiritide infusion. 
There was no evidence of hypotension or arrhythmias during 384 days of therapy. 
Nesiritide was safely given with diuretics, ACE inhibitors, beta blockers, and vasoactive 
medications(dopamine, milrinone, vasopressin, and epinephrine). Urine output improved 
by 0.7 cc/kg/hr (p=0.003) on day 1 and by 1.15 cc/kg/hr (p=0.008) on day 2. Central 
venous pressure decreased from a mean of 12.8 mm Hg to 5 mm Hg (p=0.02). Serum 
aldosterone levels decreased from a mean level of 60.6 ng/dL pre-treatment to a mean of 
30.5 ng/dL post-treatment (p=0.01). Decreased thirst occurred in 15/18 patients (83%), 
improved appetite occurred in 17/23 patients (74%), and improvement in functional status 
occurred in 23/26 patients (89%).
Conclusions: Nesiritide can safely be used in the treatment of pediatric HF. Treatment 
with Nesiritide resulted in improved urine output, decreased thirst, improved appetite, and 
improved functional status. Nesiritide should be considered a safe and effective treatment 
option whether alone or in combination with other therapies for the management of 
decompensated pediatric HF.
1029-241 Effects of the Sodium Channel Modulator BDF 9148 on 
the Developing Rabbit Heart After Myocardial Stunning
Matthias Seehase, Thomas Quentin, Elke Wiludda, Thomas Paul, Holger Schiffmann, 
Georg-August-Universität, Göttingen, Germany
BACKGROUND: Neonates often need inotropic support for heart failure after intracardiac 
repair of congenital heart defects. Despite substantial differences in myocardial 
performance, in general medication administered for inotropic support in neonates is the 
same as in adults. 
METHODS: We studied the ontogeny of myocardial function with and without inotropic 
intervention using the new Na+-channel modulator BDF 9148 in the developing isolated, 
antegrade-perfused rabbit heart (age 2 d, 28 d, n=32). Myocardial stunning was induced 
by ischemia. Myocardial function of the ischemic and non-ischemic controls was 
correlated to the gene and protein expression of the sodium-calcium exchanger (NCX) 
and the sarco-endoplasmatic reticulum Ca2+-ATPase 2a (SERCA). 
RESULTS: The NCX/SERCA expression ratio was inversely related to post natal age. 
NCX expression declined with increasing age whereas SERCA expression increased. 
With regard to the extent of myocardial stunning, neonatal hearts were less sensitive 
for hypoxia and/or ischemia than adult hearts. In neonatal post ischemic hearts NCX 
expression was signiﬁcantly higher on mRNA- and/or protein-level than in controls. In 
response to intervention with BDF 9148, we monitored positive inotropic, lusitropic, and 
chronotropic effects in the adult hearts in a concentration dependent manner. In contrast, 
in neonatal hearts diastolic relaxation deteriorated, which was reversible after wash-out 
of BDF 9148. 
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CONCLUSION: These ﬁndings suggest that only adult hearts may proﬁt from the 
administration of the Na+-channel modulator BDF 9148. It may be speculated that in 
mature myocardium a well developed sarcoplasmatic reticulum is essential for positive 
BDF effects. Further studies are necessary to clarify the risk of arrhythmia during 
application of the Na+-modulator BDF 9148.
1029-242 Evaluation of Right Ventricular Function in Patients 
With Repaired Tetralogy of Fallot With the Use of Tissue 
Doppler Imaging and Brain Natriuretic Peptide
Stella Brili, Nikolaos Alexopoulos, Georgios Latsios, Constandina Aggeli, John 
Barbetseas, Christos Pitsavos, Gregory Vyssoulis, Christodoulos Stefanadis, Athens 
Medical School, Hippokration Hospital, Athens, Greece
Background: Accurate estimation of right ventricular function in patients with repaired 
tetralogy of Fallot (RTOF) is often difﬁcult. The aim of the present study is the evaluation 
of right ventricular function of adult asymptomatic patients with RTOF by means of Tissue 
Doppler Imaging (TDI) of the tricuspid annulus and Brain Natriuretic Peptide (BNP) 
values.
Methods: 22 adult patients with RTOF and 22 age and sex matched healthy controls 
were studied by means of 2D, Doppler and TDI echo. The following measurements were 
obtained: Right ventricular diameter / Left ventricular diameter (RVD/LVD) at the 4-chamber 
view as well as systolic (Sa) and diastolic (Ea, Aa) velocities at the right ventricular free 
wall tricuspid annulus site. Serum BNP levels were measured in both groups.
Results: Patients with RTOF showed statistically signiﬁcant (p<0.001 for all) reduced TDI 
velocities compared to controls (left ﬁgure): Sa (8.19±1.20 vs. 16.26±1.10), Ea (10.66±1.80 
vs. 19.04±1.04), Aa (5.24±1.66 vs. 13.76±0.3). The BNP levels were increased in patients 
compared to controls (47.6 vs. 5.41pg/ml, p<0.001). The increased BNP concentration of 
RTOF correlated to the RVD/LVD ratio (r=0.772, p<0.001, right ﬁgure).
Conclusions: Our results indicate that although our cohort of patients was asymptomatic, 
the use of TDI and BNP easily discriminated them from the healthy controls. Moreover, 
right ventricular dilatation is correlated to BNP levels. 
1029-245 Regional Systolic and Diastolic Dysfunction of the 
Venous Left Ventricle In Patients With Corrected 
Transposition of the Great Arteries by Atrial Switch
Tudor C. Poerner, Björn Goebel, Herbert E. Ulmer, Martin Borggrefe, Raoul Arnold, 
University Hospital, Mannheim, Germany
Objectives: To investigate regional myocardial function at rest and under exercise 
in patiens with transposition of the great arteries corrected by atrial switch operation 
(cTGA).
Methods: Twenty-four patients with cTGA aged 12-33 years and 17 healthy young 
subjects underwent tissue Doppler echocardiography with strain rate imaging (TDE) at 
rest and during bycicle exercise at 1 Watt / kg body weight. Free wall of the systemic 
right ventricle (RV), ventricular septum and lateral wall of the venous left ventricle (LV) 
were scanned from apical 4-chamber-views. Longitudinal systolic (Vs) and diastolic (Ve) 
velocities, systolic strain rate (SR) and strain were determined as peak values in the 
basal, mid-wall and respectively apical segments using a dedicated software.
Results are displayed in Table 1.
Conclusions: (1) Septum and especially the free RV wall of patients with cTGA showed 
at rest and under exercise severely impaired regional systolic and diastolic performance 
indices compared to the control group. (2) Venous left ventricle of cTGA patients presented 
reduced diastolic velocities at rest, while systolic parameters were comparable to those 
of the control group. (3) Under exercise TDE revealed in patients with cTGA signiﬁcant 
lower values for strain rate, strain and peak velocities in the lateral LV wall compared 
to healthy subjects, demonstrating a reduced functional reserve of the venous LV after 
correction of TGA.




Strain (%) SR (1/s) Vs (mm/s) Ve (mm/s)
cTGA Control cTGA Control cTGA Control cTGA Control
RV: rest 15 ± 8* 36 ± 20 1.11 ± 0.61* 2.89 ± 1.69 40 ± 27* 64 ± 25 37 ± 26* 86 ± 38
RV: exercise 13 ± 6* 37 ± 17 1.49 ± 1* 3.65 ± 1.89” 38 ± 29* 67 ± 34 42 ± 27* 110 ± 54”
Septum: rest 20 ± 9* 24 ± 8 1.24 ± 0.63* 1.91 ± 0.69 25 ± 12* 34 ± 18 38 ± 22* 85 ± 27
Septum: exercise 23 ± 10 28 ± 11” 1.86 ± 1.1*” 2.39 ± 0.81” 31 ± 19* 45 ± 22” 43 ± 22* 110 ± 35”
LV: rest 19 ± 9 21 ± 9 1.64 ± 0.7 1.8 ± 1.1 53 ± 31 46 ± 25 55 ± 37* 94 ± 41
LV: exercise 18 ± 8* 23 ± 10 2.09 ± 0.86*” 2.59 ± 1.32” 76 ± 44* 98 ± 42” 60 ± 23* 136 ± 47”
1029-246 Left and Right Ventricular Function in Fetal Tetralogy of 
Fallot With Absent Pulmonary Valve
Yukiko Kado, Noboru Inamura, Futoshi Kayatani, Tomoko Kita, Osaka Medical Center 
and Research Institute for Maternal and Child Health, Izumi, Osaka, Japan
Background: Tetralogy of Fallot with absent pulmonary valve (TOF/APV) is a rare 
form of congenital heart disease with a high risk of perinatal mortality particularly when 
diagnosed before birth. The pathophysiology that leads to cardiovascular compromise in 
the perinatal period has as yet not been deﬁned. 
Objective: The aim of this study was to assess whether global left (LV) and right (RV) 
ventricular function in fetuses with TOF/APV using the Tei index([isovolumiccontraction 
and relaxation time] / ejection time) are related to outcome. 
Methods: We reviewed the fetal echocardiograms and clinical outcome of 8 fetuses 
diagnosed with TOF/APV. The LV and RV Tei index were calculated. The inside of the 
rudimentary pulmonary valve diameter / the outside rudimentary pulmonary valve 
diameter (IPV/OPV) and pulmonary insufﬁciency time / RV ejection time (PIT/RET) were 
used as indices of severity of pulmonary insufﬁciency. 
Results: Of the 8 cases of fetal TOF/APV, 4 developed cardiovascular compromise 
leading to intrauterine death in 2 and neonatal death in 2, and 4 survived the neonatal 
period. The RV Tei index was signiﬁcantly greater, and the LV Tei index tended to be 
greater, in nonsurvivors compared with survivors with TOF/APV(RV Tei: 0.90±0.17 vs 
0.30±0.28, p<0.05 ; LV Tei:0.97±0.42 vs 0.54±0.21). PIT/RET was signiﬁcantly higher 
in nonsurvivors(1.44±0.23 vs 1.02±0.20, p<0.05 ). Finally both LV and RV Tei indices 
correlated negatively with IPV/OPV(r=0.72, 0.91).
Conclusions: These data suggests that global RV and LV function can be affected in 
TOF/APV. Furthermore, more severe pulmonary insufﬁcency as suggested by extended 
IPV/OPV and worse biventricular function as assessed by Tei index likely contribute to 
the high perinatal mortality associated with this disease, and may be helpful in offering 
counseling about their outcome.
POSTER SESSION
1056  Congenital Heart Disease: Catheter-
Based Interventions
Sunday, March 06, 2005, 1:30 p.m.-5:00 p.m.
Orange County Convention Center, Hall E1
Presentation Hour: 1:30 p.m.-2:30 p.m.
1056-237 Nonsurgical Closure of Congenital Ventricular Septal 
Defects: Results and Complications
Massimo Chessa, Mario Carminati, Gianfranco Butera, Edoardo Bossone, Diana 
Gabriela Negura, Luciane Piazza, Alessandro Giamberti, Giuseppe Pomè, Marco 
Antonio Della Torre, Luca Rosti, Angelica Delogu, Manuela Drago, Alessandro Frigiola, 
Istituto Policlinico San Donato, san Donato Milanese, Italy, Italy
Objective. To report our experience on transcatheter closure of congenital ventricular 
septal defects (VSD) with Amplatzer septal occluders.
Patients. 97 patients (pts) (26 muscular VSDs and 71 perimembranous VSDs; 85 native, 
12 residual post surgery), age:16 years (range: 6 months- 64 years), weight: 34 Kgs 
(range: 6,5-90 Kgs). The VSD size was 8 mm.(range: 4.5-16 mm), mean Qp/Qs=2±0,5.
Methods. All procedures were performed under general anaesthesia, with ﬂuoroscopic 
and transesophageal echocardiographic control. The device was implanted through the 
Femoral or Internal Jugular venous route.
Results. The procedure was not performed in 2 pts (both when attempting to use the 
Membranous occluder). Satisfactory device implantation was achieved in 95 pts: a tiny 
“smoke-like” residual ﬂow though the device was rather common immediately after the 
procedure (54%), but a residual shunt was detectable in 19% after 24 hours and only in 
8% at 1 month, and 5% at 6 months follow-up. Additional catheter interventions performed 
simultaneously: device closure of atrial septal defects in 2, coil occlusion of arterial duct in 
1, stenting coarctation in1, pulmonary valvuloplasty in 2, PA stent in 1.
Acute complications: aortic regurgitation (2), tricuspid regurgitation (2), device 
embolization(2), complete A-V block (2), transient left bundle branch block and transient 
haemolysis (2). No complications were observed during a median follow-up of 8 months 
(range:2-35 months). 
Conclusions. Transcatheter closure of congenital VSDs offers encouraging results, 
giving 96% complete closure at mid term follow-up. Complications seem to be limited to 
acute phase of the procedure; to verify its feasibility, safety and effectiveness multicenter 
trials are warranted.
1056-238 Symptomatic Atrial Septal Defects In Children Under 2 
Years Of Age: To Close Or Not To Close?
Iman Kahwaji, David Teitel, Paul Stanger, Phillip Moore, University of California San 
Francisco, San Francisco, CA
Objectives: To assess the efﬁcacy of transcatheter device closure of atrial septal defects 
(ASD) in symptomatic children under 2 years of age.
Background: Symptoms associated with ASD in children under 2 years of age include 
respiratory distress, pulmonary hypertension, and failure to thrive, particularly in 
children with associated abnormalities. The efﬁcacy of device closure in these children 
is unknown.
Methods: Between Jan 2000 and Aug 2004, 23 patients under 2 years of age (median 
age 1 year, 9 d to 22 m; median weight 8 Kg, 3 to 12 Kg) had device closure of ASD using 
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moderate sedation and transthoracic echocardiography (TTE). Of 23 patients 13 had 
associated abnormalities including Ebstein’s, trisomy 21, heart block, immunodeﬁciency, 
and lung disease of prematurity. The Amplatzer device was used in 21 of 23 patients, the 
CardioSEAL device in 2. Clinical follow-up, echocardiographic, and catheterization details 
were reviewed.
Results: Symptoms were present in 21 (91%) including respiratory in 10 (recurrent 
infections), pulmonary hypertension (PHTN) in 7, failure to thrive (FTT) in 2, and cyanosis 
in 2. Baseline Qp/Qs was median of 2 (1.5 to 2.6). Device closure was successful in all 
with a ﬂuoroscopy time of 38 +/- 24 minutes. Procedural complications included transient 
supraventricular tachycardia in one and trivial pericardial effusion not requiring treatment 
in one. At a median follow-up of 14 months (1 to 54 months), 8/10 patients with respiratory 
symptoms had resolution, 6/7 patients with PHTN had normalization of right ventricular 
pressure by TTE, both patients with FTT gained to above the 5th percentile for weight, and 
both patients with cyanosis had normal saturations. Twenty of 23 had complete closure 
by TTE and 3 had trivial residual leaks. Late events included deaths in 4 patients at 1,6,7, 
and 16 months (Ebstein’s 1, immunodeﬁciency 1, respiratory failure 2), and progression of 
a preexisting 2nd degree AV block to asymptomatic 3rd degree AV block at one month.
Conclusions: Transcatheter device closure of ASD in symptomatic children under 2 
years of age is feasible and safe. The majority of patients showed marked improvement in 
symptoms, although effect on late outcome is unclear.
1056-239 Experimental Atrial Septal Defect Occlusion Using the 
Transcatheter Patch and Surgical Adhesive
Eleftherios B. Sideris, Benjamin Macuil, Vasiliki E. Sideris, Spyridon D. Moulopoulos, 
Athenian Institute of Pediatric Cardiology, Athens, Greece
Background: The Transcatheter Patch (TP) has several theoretical advandages over 
disk devices in heart defect occlusion, including wider spectrum of application (minimal 
rim requirment) and absence of wire related complications; however the method is 
relatively inconvenient requiring 48 hours of hospitalization. Accelerated TP release using 
surgical adhesives (SAs) could correct this disadvandage.
Method: Atrial septal defect (ASD) occlusion was performed in 9 piglets, using the TP 
with SA. There were 6 ASDs 10-12 mm in diameter and 3 cases of patent foramen ovale 
(PFO); in one animal the left atrial appendage (LAA) and the PFO were sequentially 
occluded. The SA used was a polyethylene glycol, applied in an inactive form to the waist 
of the patch, with later activation inside the heart. The patch was released in 15-45 min. 
Heparin was used in 5 cases.
The TP was supported by a single balloon without retention disk or proximal balloon. 
Fluoroscopy and echocardiography were used on implantation; all animals were followed 
for a period up to 3 weeks and had autopsies.
Results: All patches were released in 15-45 minutes. There were no instances of patch 
embolization or thromboembolism. Endothelialization was complete in 3 weeks. In one 
case the TP was pulled through the ASD and was attached to the inferior vena cava. 
It was retrieved and replaced by another one. In the case of sequential LAA and PFO 
occlusion, the LAA was ﬁrst occluded with the patch released in 15 minutes, followed by 
PFO occlusion and patch released in 15 more minutes.
Conclusion: Accelerated TP occlusion of experimental ASDs is feasible and safe using a 
polyethylene glycol surgical adhesive. The TP construction is simpliﬁed (no need for double 
balloon or retention disk). Heparin use is not contraindicated. Careful echocardiographic 
and ﬂuoroscopic guidance is required for the initial precise placement of the patch, since 
subsequent manipulations are not possible.
1056-240 Balloon Sizing Is Not Necessary for Closure of 
Secundum Atrial Septal Defects
Zahid Amin, David A. Danford, University of Nebraska/Creighton University/Children’s 
Hospital of Omaha, Omaha, NE
Background: Balloon sizing (BS) is considered an integral part of atrial septal defect 
(ASD) closure. In large defects with inadequate atrial septal rims, BS may increase the 
ASD size, the waist may not be easily seen, and hemodynamic compromise may occur 
if the balloon inﬂation time is long. These factors may make device selection inaccurate, 
which may result in inadvertant over-sizing of the Amplatzer septal occluder (ASO). The 
ASO has a high margin of safety because it is self-centering device, and the left and right 
discs are 14 and 10 mm larger than the waist, respectively. 
Objective: To assess whether device closure without BS is safe and feasible. 
Methods: Thirty-ﬁve pts underwent ASO placement without BS. Pts. were divided into two 
groups (A and B). In group A (pts < 18 kg), using transesophageal echocardiography, the 
left atrial systolic diameter (LASD) was measured in four chamber view and used as a 
guidance in selecting the size of the device. The left disc of the chosen ASO was equal to 
or smaller than the LASD. In group B (pts >18 kg), using intracardiac echocardiography, 
a device that was 2 to 4 mm larger than the ASD (ASD size measured in atleast two 
views) was chosen. The median weight in group A was 13.4 kg ( + 3.19) and the median 
size of the ASD was 17 ( + 4.19). The median size of the device used was 19 mm (+ 4.8). 
In group B, the median size of the ASD was 23 mm ( + 4.3) and the median size of the 
device was 22 mm ( + 2.28). Since the device to defect ratio was small, proper alignment 
of the left disc was important for device deployment. This was obtained by clock wise 
sheath rotation, partial left upper pulmonry vein or left atrial roof deployment of the left 
disc. Results: The procedure was successful in all pts. There was no incidence of device 
embolization or any other complication. There were 25 pts in group A and 10 in group B. 
Complete closure was seen in 32 pts and small residual shunt seen in 3 at 24 hours follow 
up. Follow-up is available from 1 to 20 months. 
Conclusions: Device closure of ASD is safe and feasible without BS. Avoiding BS 
decreases unnecessary oversizing of the device. LASD helps in ensuring that the device 
is not larger than the atrial septum and avoids potential complications of the ASO eroding 
the atrial wall.
1056-241 Diagnostic Predictors of Unfavorable Pulmonary Artery 
Anatomy in Tetralogy of Fallot and Pulmonary Atresia
Nicole J. Sutton, Kathy J. Jenkins, John F. Keane, Kimberlee Gauvreau, Steven D. Colan, 
James E. Lock, Boston Chioldren’s Hospital, Boston, MA
Background: While some patients with Tetralogy of Fallot and pulmonary atresia (TOF/
PA) have normal, unobstructed pulmonary arteries (PA), there is a distinct group with 
diffusely hypoplastic or stenotic PAs that are refractory to simple intervention. There is 
currently no way to determine at presentation who will develop these unfavorable PAs.
Methods: We retrospectively identiﬁed patients with TOF/PA with primary cardiology care 
at our institution over a 12 year period. Patients were classiﬁed as having unfavorable PA 
anatomy if they had diffuse, bilateral, hypoplastic or stenotic PA at nonsurgical sites on 
most recent angiography and a clinical course characterized by multiple interventions, 
persistent cyanosis, failure to achieve VSD closure and/or elevated RVp after VSD closure 
in the absence of conduit obstruction. We examined clinical and echocardiographic 
parameters at presentation to identify factors associated with unfavorable PA anatomy.
Results: Of 146 patients, 133 patients had sufﬁcient information to determine PA anatomy; 
64 (43.8%) were unfavorable. Fetal diagnosis, gender, hemoglobin or oxygen saturation 
at presentation is not related to PA anatomy category. Of 46 patients tested, 25% of 
unfavorable and 10% of favorable patients had 22q11 deletions (p=0.01). Discontinuous 
PA and presence of multiple aortopulmonary collaterals (MAPCAs) are more frequent in 
unfavorable PA patients, 25% vs. 4% (p=0.001), and 95% vs. 22% (p<0.001) respectively. 
Smaller PA size at presentation is also related to unfavorable anatomy: median RPA z 
scores -3.52 vs -1.04 (p <0.001), LPA z score -3.63 vs -1.07 (p<0.001), Nakata Index, 104 
vs 445mm/m2 (p<0.001). The best threshold for predicting unfavorable PAs is RPA z score 
of ≤ -2.0; LPA z score of ≤ -2.5, or Nakata Index of <300 mm/m2. In multivariate analysis, 
only PA size (Nakata Index <300 mm/m2, OR 19.2, p<0.001), and MAPCAs (OR 13.8, 
p=0.001) at presentation are independently related to unfavorable late PA anatomy.
Conclusions: Small PA size at presentation and MAPCAs are signiﬁcantly related to the 
development of unfavorable PA anatomy. Interventions either before or after birth that 
enlarge PAs may improve long term prognosis in TOF/PA.
1056-242 Intraoperative Angiography & Stent Implantation: 
Collaboration Between Surgeon & Interventionalist In 
The Management Of Congenital Heart Disease
Gregory H. Kurio, John J. Lamberti, David P. Bichell, Frank F. Ing, Children’s Hospital & 
Health Center San Diego, San Diego, CA
Background: Intraoperative stent implantation (ISI) has been described but guided only 
by direct vision limiting accuracy of stent (S) placement into pulmonary arteries (PA), 
possibly “jailing” vessels & increasing vascular trauma. Intraoperative angiography (IA) 
can be obtained w/ a portable C-arm ﬂuoroscopy unit in the operating room (OR). IA offers 
dynamic data useful to both surgeon & cardiologist in planning interventions or evaluating 
work before closing the pt. In addition, IA may reveal hidden problems such as vessel 
stenosis or occlusion that can then be dealt w/ immediately in the OR.
Objectives: To review our institution’s experience w/ ISI & IA.
Methods: The records of pts who had IA or ISI between July 1998 & July 2004 were 
reviewed retrospectively. Diagnosis & location of IA were noted as well as any intervention. 
Hemodynamic & angiographic data were analyzed.
Results: 32 pts were identiﬁed. Median age was 4.6 yrs (range: 2 d to 34.4 yrs). 16 pts 
had interventions only while 8 pts had IA only. The remaining 8 pts had interventions 
assisted by IA. 15 of 16 cases of IA were of PAs, most often in cases of unifocalization or 
PA-plasty. In one case, a cavopulmonary anastomosis was found to be thrombosed by IA 
& was then successfully revised. In all, 4 pts had their surgical courses altered by data 
obtained by IA. A total of 31 S were implanted in 22 pts & previously implanted S were 
further dilated in 2 pts. Minimum vessel diameter increased from 0.9-7mm before to 4-
10mm after dilation. Proximal PA pressure decreased from 45-85mmHg to 36-55mmHg. 
There was a single complication of left PA tear w/ ISI. This was rapidly & successfully 
addressed surgically.
Conclusions: IA is a viable & useful tool to aid surgery or ISI for congenital heart 
disease. Dynamic data obtained by IA can be acted upon surgically or by catheter 
intervention during a single anesthesia session. S can be more accurately placed w/ 
IA. Rare complications can easily be addressed w/ the chest open. Further studies are 
necessary to determine which pts & procedures are most amenable to such collaboration 
between surgeon & interventionalist.
1056-245 Elevated Lipoprotein(a) and Anti-phospholipid 
Antibodies are Common in Patients With Cryptogenic 
Stroke or Paradoxical Embolism Undergoing 
Percutaneous Patent Foramen Ovale Closure
Andreas Muench, Fernando Boccalandro, Gregory M. Giesler, B. Keith Ellis, Alexander 
Butkevich, Sukesh C. Burjonroppa, Catherine Carter, Richard W. Smalling, University of 
Texas Health Science Center at Houston, Houston, TX
Background: Interventional closure of patent foramen ovale (PFO) for patients with 
cryptogenic stroke may reduce the risk of recurrent thromboembolic events. Limited data 
is available on the frequency of hypercoagulable states in these patients. We reviewed 
coagulation parameters in patients with cryptogenic stroke, peripheral embolism or 
transient ischemic attack (TIA) who underwent PFO closure.
Methods: 118 patients (age 15-80, average 48.5 years) suffered stroke(s) (N=101), 
peripheral embolism (N=2) and/or TIA (N=28). The majority had PFO (117) and one had 
atrial septal defect. All patients underwent percutaneous closure of the defect (CardioSeal: 
N=55, Amplatzer: N=63) from 12/1999 to 8/2004. Follow-up was up to 3 years. Patients 
were screened for inherent risk factors for arterial and venous thrombosis.
Results: Lipoprotein(a) levels were elevated in 17/67 (25.4%) patients; 9 of which had 
very high levels (>60 mg/dL). Abnormalities in phospholipid antibodies (anticardiolipin or 
beta-2-glycoprotein 1) were found in 23/94 (24.5%). 6% were heterozygous for Factor-
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V-Leiden. Homocysteine was elevated in 11% of patients while other abnormalities 
including lupus anticoagulant, prothrombin mutation 20210, protein S, C or antithrombin-
III deﬁciency were rare (<3%).
Conclusion: Elevated levels of lipoprotein(a) and antiphospholipid antibodies may be a 
risk factor for paradoxical embolism in individuals with PFO, therefore patients may beneﬁt 
from a more aggressive treatment strategy.
Inherent risk factors for thrombosis in patients with presumed paradoxical embolism 
and PFO 
N Tested N Abnormal Percent abnormal
Lipoprotein(a) 67 17 (>30 mg/dL) 25.4
Anti-phospholipid Antibodies 94 23 24.5
Homocysteine 89 10 (>11.4 mcmol/L) 11.2
Factor V Leiden 83 5 (heterozygous) 6.0
Protein S deﬁciency 77 2 2.6
Prothrombin mutation 20210 65 1 (heterozygous) 1.5
Protein C deﬁciency 72 0 0
Lupus anticoagulant 84 0 0
Antithrombin III deﬁciency 81 0 0
1056-246 Occluder Related Complications of Transcatheter Patent 
Foramen Ovale and Atrial Septum Defect Closure: 
Inﬂuence of Protamin Given During the Procedure on 
Incidence of Thrombus Formation on the CardioSEAL-
StarFLEX-Device
Madlen Reschke, Ralph Hein, Franziska Buescheck, Margaret Taaffe, Ilona Hofmann, 
Stefan Ostermayer, Thomas Middeldorf, Klaus Lang, Kai Billinger, Thomas Trepels, 
Hildegard Lissman Jensen, Albrecht Roemer, Neil Wilson, Horst Sievert, CardioVascular 
Center Frankfurt, Frankfurt, Germany
Objectives: The purpose of this study was to evaluate the inﬂuence of protamin on 
incidence and clinical course of thrombus formation on the CardioSEAL-StarFLEX-device.
Background: A higher incidence of thrombus formation on this device compared to some 
other devices has been described. It has been assumed that protamin given during the 
procedure to facilitate early sheath removal contributed to this adverse event.
Methods: 285 interatrial defects were closed with the CardioSEAL-StarFLEX-device 
under transesophageal echocardiography(TEE) or intracardiac echo imaging. In 121 
consecutive patients, protamin was given to antagonize heparin, in 164 consecutive 
patients not. TEE was scheduled at 4 weeks and 6 months.
Results: After four weeks 11 of all followed patients (n=210) displayed thrombus 
formation on the device: 6/94 of the patients with protamin and 5/116 of the patients 
without protamin. After 6 months two of all followed patients (n=197) displayed thrombus 
formation on the device: 1/112 of the patients with protamin and 1/85 of the patients 
without protamin.
Thrombus size varied from 1 to15mm in diameter. Thrombi were more frequently 
diagnosed on the left side. Two patients had an additional thrombus in the right atrium. 
In 9/13 patients, the thrombus resolved under anticoagulation therapy with warfarin or 
heparin. In two patients, the thrombus was removed surgically (together with the device).
Conclusion: Protamin given during the procedure to facilitate early sheath removal did 
not cause thrombus formation on the CardioSEAL-StarFLEX-device.
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1085-237 Spatial and Temporal Regulation of Matrix 
Metalloproteinase-9 Transcriptional Activation 
Following Discrete Myocardial Injury
J. Philip Saul, Rupak Mukherjee, James A. Bruce, David M. McClister, Jr., Claire 
M. Allen, Jeffrey S. Austin, M. Elizabeth Fini, Medical University of South Carolina, 
Charleston, SC, University of Miami School of Medicine, Miami, FL
Background: Radiofrequency (RF) ablation of the myocardium causes discrete 
sites of injury. RF scars can expand, altering the extracellular matrix (ECM). Matrix 
metalloproteinases (MMPs) contribute to ECM remodeling and one MMP type, MMP-
9, contributes to adverse myocardial remodeling. However, transcriptional induction of 
MMP-9 following myocardial injury remains unexplored. This study examined MMP-9 
gene promoter (M9PROM) activation post-myocardial RF injury using mice in which the 
M9PROM was fused to a β-galactosidase (β-gal) reporter.
Methods and Results: RF lesions (0.5 mm probe, 80oC, 30s) were created on the LV 
epicardium of M9PROM mice (n=62) and terminally studied at 1hr, 1d, 3d, 7d, 14d, and 
28d post-RF. M9PROM activation was localized through β-gal staining. RF scar area and 
the area of β-gal staining were measured and normalized to LV area (Figure). RF scar 
size increased from 1hr post-RF values by 7d and continued to increase through 28d, 
indicative of RF scar expansion. M9PROM activation became evident at 3d, peaked at 
7d, and was non-detectable by 28d post-RF. At 3 and 7d post-RF, M9PROM activation 
radiated from the scar towards the remote myocardium, recruiting previously viable 
myocardium in the RF scar expansion process.
Conclusions: These unique ﬁndings provide insight into spatiotemporal pattern of 
MMP-9 transcriptional activation following discrete myocardial injury and provide a 
temporal window to interdict in MMP-9 activation as a means to attenuate post-RF scar 
expansion.
1085-238 Mechanisms of Right Atrial Tachycardia Occurring Late 
After Surgical Closure of Atrial Septal Defects
Isabelle Magnin-Poull, Christian de Chillou, Hielko Miljoen, Marius Andronache, Etienne 
Aliot, University Hospital Nancy, Vandoeuvre les Nancy, France
Introduction: In patients without structural heart disease the most frequently occurring 
AT is common atrial ﬂutter. In patients with repaired congenital heart disease other 
mechanisms of AT may occur, due to the presence of an atriotomy, that can provide a 
substrate for reentry. The aim of the present study was to identify the mechanisms of atrial 
tachycardia (AT) occurring late after atrial septum defect (ASD) repair, with the help of a 
three dimensional electroanatomical mapping system.
Methods and Results: Twenty-two consecutive patients presenting with atrial 
tachycardia (AT) underwent complete electroanatomic mapping (CARTO®, Biosense) 
of spontaneously occurring and inducible right ATs. Complete maps of 26 ATs were 
obtained. Three tachycardia mechanisms were identiﬁed: single-loop macroreentrant 
atrial tachycardia (MAT) (n=7), double-loop MAT (n=18) and focal atrial tachycardia (n=1). 
In all MATs, protected isthmuses were identiﬁed as the electrophysiological substrate of 
the arrhythmia: most frequently the cavotricuspid isthmus (n=24), and a gap between the 
inferior vena cava and a line of double potentials (n=11). A mean number of 13.5±2.1 
radiofrequency applications were delivered to transect these critical parts of the circuit. 
During a follow-up of 25±16 months the RF-ablation was acutely successful in all patients. 
Thirteen patients (59%) had an early recurrence of MAT and needed an additional ablation 
procedure. One of those patients needed two additional ablation procedures.
Conclusions: Three dimensional electroanatomic mapping is useful to identify post-
surgical AT mechanisms ; the CTI isthmus is involved in 92% MAT and if right atrial free 
wall abnormal tissue related to surgical scar is present this substrate contributes to the 
MAT circuit.
1085-239 Predictors Of Junctional Ectopic Tachycardia Following 
Surgery For Congenital Heart Disease
Anjan S. Batra, Davis S. Chun, Tiffanie R. Johnson, Elaine M. Maldonado, Brandy A. 
Kashyap, Jackie Maiers, Chris L. Lindblade, John Brown, Mark Rodefeld, Joyce E. 
Hubbard, Indiana University School of Medicine, Indianapolis, IN
Background: Junctional ectopic tachycardia (JET) often follows surgery for congenital 
heart disease and is associated with increased morbidity. Previous reports investigating 
predictors of JET have found a correlation between JET and surgeries involving direct 
injury to the conduction system, hypomagnesemia, and use of inotropes. The exact cause 
of JET however remains unclear. This study is designed to evaluate the predictors of JET 
in this population.
Methods: We prospectively followed 336 consecutive patients with a mean age of 4.02 
± 7.04 years undergoing surgery for congenital heart disease at our institution over a 1-
year period. Continuous electrocardiography was reviewed every 24 hours from surgery 
until discharge.
Results: The incidence of JET was 8% (n=27). Repairs with the highest incidence of JET 
included arterial switch operation (3/13, 23%), AV canal repair (4/19, 21%), and Norwood 
palliation (2/10, 20%). When compared to patients with no arrhythmias, patients with JET 
were more likely to be younger (1.52 ± 2.34 vs. 3.87 ± 6.65 years, p<0.001), have had 
longer cardiopulmonary bypass times (131 ± 44 vs. 110 ± 55.9, p<0.01), and have a 
higher inotropic score in the postoperative period (6.26 ± 7.55 vs. 1.76 ± 8.49, p<0.01). 
Onset of JET did not correlate with either right ventricular outﬂow tract reconstruction or 
electrolyte abnormalities such as hypomagnesemia. Median onset of JET was on post-
operative day 1 (range 1-6 days) and median duration was 1 day (range 1-13 days). 
Median rate of JET at onset was 195 bpm (range160-230 bpm). Patients with JET spent 
longer in the hospital (21.3 ± 20.5 vs. 11.1 ± 16.6, p<0.001). JET was successfully treated 
in 96% (n=26) of the patients, with 48% receiving conventional measures (cooling and 
sedation) and 48% receiving amiodarone.
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Conclusion: Patients undergoing arterial switch operation, AV canal repair, and Norwood 
palliation are at a higher risk of postoperative JET, especially when associated with a 
longer cardiopulmonary bypass time and greater inotropic support. These patients may 
be candidates for prophylactic treatment of JET.
1085-240 Efﬁcacy of Biphasic Waveform Compared with 
Monophasic Waveform for Cardioversion of Atrial 
Flutter in Patients with Congenital Heart Disease
Anjan S. Batra, Babar S. Hasan, Helen Flippin, Roger A. Hurwitz, Indiana University 
School of Medicine, Indianapolis, IN
Background: Transthoracic electrical cardioversion using a monophasic waveform has 
been the most common method converting persistent atrial ﬂutter into sinus rhythm. 
Recently, cardioversion with a biphasic waveform has shown promising results for 
treatment of atrial ﬂutter. However, this efﬁcacy has not been demonstrated in patients 
with congenital heart disease. This study compares cardioversion outcomes in 2 
sequential groups of patients with atrial ﬂutter and congenital heart disease undergoing 
transthoracic cardioversion.
Methods: Records of 102 consecutive cardioversions undertaken in the electrophysiology 
laboratory between 1990- 2004 were reviewed. Fifty-four patients (mean age 16.7 ± 3.2 
yrs) received monophasic cardioversion, and the remaining 48 patients (mean age 17.4 
± 6.4 yrs) underwent biphasic cardioversion. Underlying congenital heart disease (i.e., 
Fontan, Mustard, and other structural heart disease) were similar in both treatment groups. 
Antiarrhythmic medications including amiodarone, digoxin and procainamide were similarly 
used in both groups. Mean systemic ventricular ejection fraction was not statistically different 
between the monophasic and biphasic groups (53 ± 17% and 48 ± 12%).
Results:  Procedure success rate was 88.9% (48/54) in the monophasic group compared 
to 100% (48/48) in the biphasic group (p=0.028). The mean energy required for procedural 
success was 1.72 ± 1.1 J/kg in the monophasic group compared to 1.08 ± 0.9 J/kg in the 
biphasic group (p<0.002). The mean number of attempts before achieving procedural 
success was 1.7 ± 1.1 for the monophasic cardioversion group and 1.3 ± 0.9 for the 
biphasic cardioversion group (p=0.007). No major acute complications were observed 
in either group.
Conclusion: Biphasic waveform shock transthoracic cardioversion for atrial ﬂutter in 
patients with congenital heart disease is associated with higher cardioversion success 
rates and lower energy requirements compared with conventional monophasic waveform 
shocks. These ﬁndings provide the impetus for more widespread use of devices utilizing 
biphasic waveforms in patients with congenital heart disease.
1085-241 The Pure Potassium Channel Blocker (Nifekalant 
Hydrochloride) for Postoperative Junctional Ectopic 
Tachycardia and Ectopic Atrial Tachycardia in Infants 
with Congenital Heart Disease and Impaired Ventricular 
Contraction
Satoshi Yasukochi, Nagano Children’s Hospital, Toyoshina, Japan
Background: Nifekalant Hydrochloride(Nif), pure potassium channel (IKr) blocker, is a 
new anti-arrhythmic drug for ventricular tachycardia(VT) without deteriorating ventricular 
function. However no experience has been reported in use for infants with congenital 
heart disease (CHD) who had junctional ectopic tachycardia(JET) or ectopic atrial 
tachycardia(EAT).
Aim: The purpose of this study is to clarify the feasibility and efﬁcacy of Nif in infants, 
presenting a JET and EAT after surgery for CHD with impaired ventricular contraction.
Subjects and methods: Five infants.with various CHD (Age :12 days to 13 months ( 3 
mo.as a median) and Body Weight :2.3 to 7.45Kg ( 4.8)) developed JET/EAT from 0 to 
12 days after surgery (Jatene(1), Bi-directional Glenn(1), Norwood(1), VSD closure(1) , 
repair of total anomalous pulmonary venous connection (1)) , were enrolled. All clinical 
records and ECGs were retrospectively reviewed and analyzed.
Results: Of 5, 3 developed JET and 2 had EAT with narrow QRS. The ventricular rate 
on JET ranged 180 to 200 bpm and those on EAT with 250 to 300 bpm, All demonstrated 
impaired ventricular contraction whose fractional area change (FAC) of the ventricle 
ranged 0.14 to 0.15 (normal control value above 0.35). Since all showed resistant to 
anti-arrhythmic treatment including hypothermia, overdrive pacing, digoxin and sodium 
channel blockers, Nif was started by continuous d.i.v. at the dosage of 0.3 - 0.4mg/Kg/h 
for 3 - 9 days (7), as well as ventricular pacing ranging 160 to 170 bpm. Within 6 hours, 
the basal heart rate of all could show slow down below pacing rate. All could be paced at 
the rate of 160- 170bpm and resulted in sinus rhythm within 5days.
Becoming sinus rhythm, all improved FAC as 0.32 to 0.45. No complication was found. 
The mechanism of Nif on JET and EAT is considered as slowing automaticity by 
suppressing delayed activated depolarization. In conclusion, nifekalant hydrochloride is 
a potent effective anti-arrhythmic drug for postoperative JET/EAT in infants with CHD with 
improving ventricular function.
1085-242 The Efﬁcacy of Implantable Loop Recorders in Children
Muthukumaran C. Sivaprakasam, Jr., Joseph J. Vettukattil, Sr., Shantabanu 
Chakrabarthi, Jr., Graham Stuart, Sr., Paul Roberts, Sr., Anthony P. Salmon, Sr., 
James Gnanapragasam, Barry R. Keeton, Sr., John Morgan, Sr., Southampton General 
Hospitals NHS Trust, Southampton, United Kingdom, Bristol Children’s Hospital NHS 
Trust, Bristol, United Kingdom
Objectives: Evaluate efﬁcacy of implantable loop recorder (ILR) in establishing 
symptom-rhythm correlation [SRC] in children with syncope, near syncope or palpitations. 
Methods: Retrospective study of children who had ILR from two major tertiary centres 
from January 1998 to February 2004. Inclusion criteria were ILR implantation age < 18 
years and a minimum follow-up period of at least 1 month. All ILR-stored events were 
analysed at the time of the symptomatic event. Results: Forty-nine implantable loop 
recorders were inserted. Mean age at insertion was 12.1 [range 0.7-18], 33 were males 
and 28 had general anaesthesia. There was no immediate complication. All patients 
were discharged within 24hrs. Median time interval from the date of presentation to 
the insertion of ILR was 5.5 months [range 1day-7.4 years]. Symptoms leading to ILR 
implantation were syncope (N=24), near-syncope (N=5), palpitations (N=16) and other 
(N=4). Thirty children remained symptomatic. SRC was achieved in 29 (96%). The ILR 
failed to detect VF in a child with heart block requiring pacemaker following resection 
of purkinjioma. The average time between ILR implantation and diagnosis was 93 days 
[range 1-486 days]. Deﬁnite diagnoses were made in all patients including 13 with sinus 
tachycardia leading to reassurance and discharge. Speciﬁc treatment was achieved in 
17/50 (34%). This included prolonged sinus pause needing pacemaker insertion (5), radio 
frequency ablation of supraventricular tachycardia (5), atrial arrhythmias controlled with 
medication (2), intermittent heart block (1) and nodal rhythm requiring pacemaker (1), 
ablation of ventricular arrhythmia (1), His bundle tachycardia (1) and inappropriate sinus 
tachycardia needing beta blockers (1). Five remained asymptomatic within the life period 
of ILR. Fourteen children are yet to have symptoms. Twenty-four ILRs were explanted with 
a mean duration 436 days [range 2-889]. Complications related to ILR included pain and 
redness at the ILR site (4), wound infection (1) and keloid formation (1). Conclusion: 
Establishing SRC in younger children is difﬁcult and Implantable Loop Recorder is safe 
and effective for arrhythmia detection and management.
1085-245 Pulmonary Valve Replacement Reduces QRS Duration 
and Right Ventricular Size Late After Repair of Right 
Ventricular Outﬂow Tract Obstruction
Abdul Doughan, Michael McConnell, Teresa Lyle, Wendy Book, Emory University School 
of Medicine, Atlanta, GA
Background: Chronic pulmonary regurgitation (PR) late after repair of right ventricular 
outﬂow tract obstruction (RVOTO) may lead to progressive right ventricular (RV) dilatation 
and QRS complex prolongation on the electrocardiogram (ECG). Prolonged QRS duration 
has been found to predict adverse arrhythmic events. We sought to evaluate the effect of 
pulmonary valve replacement (PVR) on maximal QRS duration and ventricular volumes 
in patients with signiﬁcant PR late after repair of RVOTO.
Methods: We reviewed the hospital records, ECGs and echocardiograms of twenty-
one patients who underwent PVR late after RVOTO repair. Maximum QRS duration 
was measured from standard ECGs before and after PVR. Right and left ventricular 
volumes were calculated and compared in thirteen patients using two-dimensional 
echocardiography. Clinical improvement was established by means of the NYHA 
classiﬁcation.
Results: Preoperatively, ﬁfteen patients were in NYHA class II-IV. At a mean follow-up of 
7 ± 8 months after PVR, all patients have had substantial improvement and are in NYHA 
functional class I. RV end-diastolic volume (RV-EDV) decreased from 148.6 ± 61.9 to 
113.4 ± 43.5 mL (P<0.01). Maximal QRS duration decreased from 153 ± 34 to 142 ± 29 
ms (P<0.01). The change in QRS duration was most signiﬁcant in patients with a baseline 
QRS > 130 ms (176 ± 15 to 160 ± 18 ms; P < 0.001). RV-EDV correlated with QRS 
duration before PVR (r = 0.93, P < 0.0001) as well as after PVR (r = 0.82, P < 0.001). 
Conclusions: In patients with PR and RV dysfunction late after repair of RVOTO, PVR 
reduces RV volumes with concomitant improvement in exercise tolerance and shortening 
of the QRS complex duration. The presence of QRS prolongation on serial surveillance 
ECGs may be used as an indicator of RV dilatation as well as a prompt to consider 
the need for PVR before the onset of irreversible myocardial dysfunction and serious 
dysrrhythmias.
1085-246 Tissue Doppler Echocardiography Combined With a 
New 2D Strain Method for Analysis of Left Ventricular 
Function in Resynchronization Therapy in Children With 
Congenital Heart Disease
Phat Pham, Seshadri Balaji, Irving Shen, David Stuesse, Richard Reed, Ross M. 
Ungerleider, David J. Sahn, Oregon Health & Science University, Portland, OR
Background: We correlated tissue Doppler imaging (TDI) and a new 2D strain method as 
efﬁcacy indices for resynchronization therapy in acutely post-operative congential heart 
disease (CHD) pts.
Methods: We studied 10 children (3mo - 5.4 yrs, median 5.5mo), with CHD (TOF=3, 
atrioventricular septal defect=2, VSD=2, sinus venosus ASD= 2, TGA=1), immediately 
post-operative for deﬁnitive repair, with epicardial (2 RA) and ventricular wires (2 right 
ventricular [RV], 1 left ventricular [LV]). Pacing strategies include atrial pacing (AOO), 
conventional dual-chamber pacing (CDOO) using RV leads, and biventricular pacing 
(BDOO) using RV and LV leads. Pacing sequences lasted 10 minutes, then echo, standard 
ECG and hemodynamic data were acquired. A GE/VingMed Vivid 7 system was used to 
acquire TDI encoded data from 4-chamber views (120-160 fps), analyzed with EchoPac® 
scanline and the new 2D strain software.
Results: TDI derived strain rate deﬁned isovolumic tensing (IVT) and peak systolic 
contraction (PSC). Compared to AOO, CDOO showed no change in the timing of RV IVT 
and PSC, however, the LV IVT and PSC time was signiﬁcantly delayed (p=0.0002) from 
the initial QRS. Timing between RV and LV events was not signiﬁcantly changed in BDOO 
when compared to AOO. LV global strain as a function of synchronization was signiﬁcantly 
decreased in CDOO (p=0.0003), and improved with BDOO (p=0.002).
Conclusions: The new 2D strain method is effective in the assessment of ventricular 
resynchronization in children.
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1113-239 Heart Rate Turbulence And Heart Rate Variability Predict 
Sudden Cardiac Death In Patients With Congenital Heart 
Disease
Astrid E. Lammers, Harald Kaemmerer, Regina Hollweck, Raphael Schneider, Petra 
Barthel, Siegmund Braun, Annette Wacker, Silke Brodherr-Heberlein, Michael Hauser, 
Andreas Eicken, Georg Schmidt, John Hess, Klinik fuer Kinderkardiologie und 
angeborene Herzfehler, Deutsches Herzzentrum Muenchen, Munich, Germany, Erste 
Medizinische Klinik, Klinikum Rechts der Isar, Technische Universitaet Muenchen, 
Munich, Germany
Background: Heart rate turbulence (HRT) and heart rate variability (HRV) are powerful 
ECG related risk predictors for mortality in chronic heart failure and after myocardial 
infarction. No data exist regarding the predictive value of HRT and HRV in patients with 
congenital cardiac disease (CCD). The objective of the current study was to assess the 
prognostic value of HRT and HRV for risk stratiﬁcation in adolescents or adults with CCD.
Methods and Results: 43 patients with CCD, aged 13-72 years, were included in this 
prospective clinical study. Parameters of HRT (Turbulence onset = TO, Turbulence slope 
= TS) and HRV (standard deviation of all normal-to-normal intervals = SDNN, standard 
deviation of mean values for all normal-to-normal intervals over 5 minutes = SDANN and 
square root of the mean square differences of successive RR intervals = RMSSD) were 
calculated from a Holter-ECG. In addition serum brain natriuretic peptide (BNP) was 
measured and clinical functional class (FC I-IV) was determined. All cause mortality or 
cardiac arrest were used as study end points.
The mean clinical follow up was 27 ± 12.7 months. Five patients died during follow-up, 
another two patients were successfully resuscitated. Six of these patients had abnormal 
TO and TS values. On univariate analysis, BNP value (p=0.002), uric acid (p=0.0045), 
cortisol (p=0.0003), TS (p=0.0135), SDNN (p=0.004), SDANN (p=0.005), HRVTI (p=0.009), 
abnormal TO or TS (p=0.007, p=0.002) as well as abnormal TO and TS (p=0.0001) were 
associated with impaired prognosis. On multivariate analysis abnormal TO and TS was 
found to be the strongest independent risk stratiﬁer (hazard ratio 61.5, p=0.0002).
Conclusion: The present study veriﬁes for the ﬁrst time the prognostic value of HRT 
and HRV in patients with congenital cardiac disease. Our data indicate that HRT and 
HRV predict survival in unselected CCD patients with various diagnoses. In addition, our 
results suggest that HRT may even be a stronger prognostic predictor than established 
markers of cardiac autonomic dysfunction like HRV. The combined use of HRT, HRV and 
markers of neurohormonal activation like BNP may further improve the prognostic value.
1113-240 T wave Alternans in Adult Patients after the Mustard 
Procedure for Transposition of Great Arteries
Omer Goktekin, Sonya V Babu-Narayan, Philip J. Kilner, Richard Sutton, Michael A. 
Gaztzoulis, Royal Brompton Hospital, London, United Kingdom, Osmangazi University, 
Eskisehir, United Kingdom
Background: Microvolt T wave alternans (TWA) is a new non-invasive method which has 
been shown to identify patients at increased risk of cardiac arrest and sudden cardiac 
death from ventricular arrhythmias in ischemic heart disease and cardiomyopathies. 
Arrhythmia and sudden death are a signiﬁcant cause of morbidity and mortality late after 
atrial redirection surgery (Mustard or Senning) for transposition of the great arteries. 
Post-operatively such patients have a right ventricle sustaining systemic pressure over a 
lifetime and are therefore at risk of late ventricular dysfunction. We hypothesised that TWA 
would be present and sought to examine the relationship between TWA and systemic 
right ventricular ﬁbrosis.
Method: Seventeen patients (11 male, mean follow-up from atrial redirection surgery of 
26.5±12.4 years) were studied so far. All patients had contrast enhanced cardiovascular 
magnetic resonance imaging. Nine patients with right ventricular (RV) myocardial ﬁbrosis 
suggested by delayed enhancement magnetic resonance and 8 patients without ﬁbrosis 
had TWA testing. TWA was measured during submaximal treadmill exercise by the 
CH2000 system (Cambridge Heart, Inc) in all patients. Positive TWA was deﬁned as an 
alternans voltage amplitude ≥1.9 µV during exercise at a heart rate of 105-120 beats per 
minute with an alternans ratio (signal-to-noise ratio) ≥3 for at least 1 minute.
Results: TWA was positive in 5 patients (29%), negative in 10 patients (58%) and 
indeterminate in 2 (11%). There was a trend towards decreased RV ejection fraction and 
increased RV mass in the 5 patients with TWA (44 ± 23 vs 62 ± 5%, NS, 119 ± 53 vs 81 ± 
18, NS). All positive TWA tests were in the RV ﬁbrosis group (5/9 vs 0/8, p<0.05). Patients 
with RV myocardial ﬁbrosis were older than those without (32 vs 23, p<0.01).
Conclusion: TWA was relatively common and related to RV myocardial ﬁbrosis seen in 
adult patients late after the Mustard operation. This may suggest that myocardial ﬁbrosis 
plays a role in the etiology of sudden cardiac death in this group of patients and warrants 
further investigation.
1113-241 Atrial Flutter in Adults With Congenital Heart Disease: 
Mapping and Long Term Outcome
Steven K. Furer, David B. Bharucha, J. Anthony Gomes, Davendra Mehta, Mount Sinai 
School of Medicine, New York, NY
Background: Atrial ﬂutter (AFL) is the most frequently encountered cardiac arrhythmia 
in adults with congenital heart disease (ACHD). Radiofrequency ablation (RFA) is often 
attempted in these patients, but the anatomic circuit and consequently, ablative therapy, 
may differ from AFL in patients with no underlying heart disease. This study sought to 
assess the AFL circuits and outcome of RFA in ACHD.
Methods: Conventional activation mapping, electro-anatomical mapping, and entrainment 
mapping were performed for 20 AFLs in 13 (9 female) patients with ACHD (mean age 39, 
range 24-67 years). All patients had previous surgical repair, 6 for atrial septal defects, 
4 for tetralogy of Fallot, 2 for transposition of the great arteries and one for ventricular 
septal defect. All patients presented with electrocardiographic features suggestive of AFL. 
Following mapping, RFA was attempted in all patients. Patients have been followed for a 
mean of 23 months (range 5-43 months).
Results: Based on all three mapping techniques, typical isthmus-dependent counter 
clockwise AFL was seen in 14/20 (70%) instances. Four arrhythmias were atypical AFL 
(scar related), and 3 were focal atrial tachycardia. Three patients had recurrent arrhythmias 
that were different from the initial arrhythmia and 2 patients had two arrhythmias at the 
time of initial study. All 4 patients with tetralogy of Fallot had typical AFL that was not 
related to scar. Scar related AFLs were seen in 2 patients with an atrial septal defect and 
1 patient with a ventricular septal defect. One patient had recurrence of typical AFL twice 
despite successful ablation. Overall, immediate post-procedural success rate of RFA in 
those with typical AFL was 13/14 (93%). The success rate in those with atypical AFL was 
3/4 (75%). Five of the 13 patients (38%) had recurrence of AFL, 3 had a new arrhythmia 
and 2 had an arrhythmia identical to the initial tachycardia.
Conclusion: Despite atriotomy scar, typical AFL is the most commonly seen atrial 
arrhythmia in this population of ACHD. With the use of electro-anatomical and entrainment 
mapping, RFA is highly successful. Recurrence rates can be signiﬁcant, however, the 
recurrent arrhythmia is often different from the one ablated.
1113-242 Hemodynamic Predictors for Favorable Outcomes of 
Severe Resting Pulmonary Hypertension After Surgical 
Repair in Patients With Acyanotic Congenital Heart 
Disease
Duk-Woo Park, Soo-Jin Kang, Kwan Ho Ko, Kyoung Ha Park, Mi Jeong Kim, Jong-Min 
Song, Duk-Hyun Kang, Jae-Kwan Song, Asan Medical Center, Seoul, South Korea
Background: It is difﬁcult to predict the outcomes of patients with acyanotic congenital 
shunt disease (CSD) and severe resting pulmonary hypertension (PHT).
Methods: Cardiac catheterization data of adult patients with CSD and PHT during the last 
10 years were retrospectively analyzed. PHT was deﬁned as the peak pressure gradient 
of tricuspid regurgitation (PGTR) measured by CW Doppler > 60 mmHg or bidirectional 
shunt documented by color Doppler.
Results: A total of 30 patients with PGTR of 92.7±22.6 mmHg was enrolled. Surgery 
was done in 17 patients (57%, group A), and was not recommended in the remaining 
13 patients (group B). PGTR, pulmonary vascular resistance (PVR), and pre- and post 
O2 inhalation resistance ratio (RP/RS) were signiﬁcantly higher in group B. In group A, 
dramatic decrease of PGTR from 86±18 to 36±14 mmHg was observed in 11 patients 
(65%, group A1), and the other 6 patients (group A2) showed no signiﬁcant change from 
79±14 to 66±15 mmHg. Baseline systemic vascular resistance (SVR) was the only factor 
showing signiﬁcant difference between group A1 and A2 (OR=1.39, 95% CI 1.02-1.92, 
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p<.05). Post O2 inhalation PVR < 10.9 and baseline SVR <38.8 Woodunits×M
2 could 
predict decrease of PHT with sensitivity and speciﬁcity of 82% and 100%, respectively.
Conclusions: In patients with suspicious Eisenmenger reaction, dramatic decrease of 
PHT could be obtained after surgical repair of CSD in considerable numbers of patients, 
which can be predicted by post O2 inhalation PVR and baseline SVR. 
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1114-237 A Randomized, Double-Blinded, Placebo-Controlled 
Trial of Tri-iodothyronine in Neonatal Heart Surgery
Andrew Mackie, Karen Booth, Jane Newburger, Kimberlee Gauvreau, Peter Laussen, 
James DiNardo, Pedro del Nido, Stephen Huang, Jodi Bartlett, Ellen McGrath, Stephen 
Roth, Children’s Hospital Boston, Boston, MA
Background: Serum tri-iodothyronine (T3) levels are reduced following cardiopulmonary 
bypass (CPB), reaching a nadir 48-72 hours postoperatively. This may be physiologically 
important, because T3 has inotropic properties. Several studies have suggested that T3 
supplementation after pediatric cardiac surgery improves clinical outcomes.
Methods: We performed a single-center, randomized, double-blinded, placebo-controlled 
trial of T3 supplementation in neonates undergoing either a Norwood procedure or two-
ventricle repair of interrupted aortic arch. Randomization was stratiﬁed by surgeon and 
cardiac diagnosis. Patients were assigned to either a continuous infusion of T3 (0.05 
mcg/kg/hr) or placebo for 72 hours after CPB. Primary endpoints were cardiac index (CI) 
48 hours after surgery and a composite clinical outcome score consisting of death, use 
of extracorporeal membrane oxygenation, and the number of days until a negative ﬂuid 
balance, sternal closure, and extubation were achieved. Higher scores implied worse 
clinical outcome.
Results: We enrolled 42 patients (T3: 22, placebo: 20). Baseline characteristics were 
similar in the treatment groups. Study drug was discontinued prematurely for 2 patients 
in the T3 group, due to hypertension (n=1) and ectopic atrial tachycardia (n=1). Free and 
total T3 levels were signiﬁcantly higher in the T3 as compared to the placebo group at 24, 
48, and 72 hours postoperatively (p<0.001). CI was 2.11 ± 0.64 L/min/m2 (T3) versus 2.05 
± 0.72 L/min/m2 (placebo) (p=NS) 48 hours after surgery. Mean clinical outcome scores 
were 1.55 ± 1.30 (T3) versus 2.70 ±1.87 (placebo) (p=0.046). Time to achieve a negative 
ﬂuid balance was shorter in the T3 as compared to the placebo group (2.05 ± 0.79 versus 
2.50 ± 0.51 days, respectively) (p=0.027). No serious adverse events were attributed to 
T3 administration. There were no in-hospital deaths in either group.
Conclusions: In this pilot trial, T3 supplementation for 72 hours postoperatively was safe 
and resulted in better clinical outcome scores and more rapid achievement of negative 
ﬂuid balance, but CI was not signiﬁcantly improved. In the future, T3 supplementation 
should be tested in larger, multi-center studies.
1114-238 Neurodevelopmental Outcome Following VSD Repair in 
Infancy
Jonathan R. Kaltman, Gail P. Jarvik, Judy Bernbaum, Marsha Gerdes, Gil Wernovsky, 
Elaine H. Zackai, Robert R. Clancy, Susan C. Nicolson, Thomas L. Spray, J. William 
Gaynor, The Children’s Hospital of Philadelphia, Philadelphia, PA
Background: Cross-sectional studies of intermediate term survivors of infant cardiac 
surgery have revealed a high frequency of neurodevelopmental (ND) disabilities. Little 
data exists regarding ND outcome of infants having surgery for ventricular septal defect 
(VSD).
Methods: All children < 6 months with VSD (with or without coexisting coarctation of the 
aorta) participating in a prospective trial assessing the effects of genetic polymorphisms 
on ND disabilities were eligible. Assessment at 1 year of age included the Bayley Scales of 
Infant Development, which yields the Mental Development Index (MDI) and Psychomotor 
Development Index (PDI), both with expected mean of 100 ± 15.
Results: At age 1 year, 50 (VSD alone = 36; VSD/coarctation = 14) returned for 
evaluation. At birth, microcephaly (head circumference < or = 5%) was present in 18%; 
median birth weight was 3.2 kg (range 1.6 - 5.1). Median age at surgery was 2.3 months 
(range 0 - 5.9). The median cumulative total support time was 66.5 minutes (range 24 
- 250). 23 pts underwent at least one period of deep hypothermic circulatory arrest. Two 
patients required one additional operation. At 1 year, microcephaly was present in 18%. 
There was a conﬁrmed or suspected genetic syndrome in 18 pts, including 4 with 22q11 
deletion. The median MDI was 93 (56 - 117); 6% had scores < 70. The median PDI was 
89 (50 - 117); 20% had scores < 70. Mean MDI and PDI scores were signiﬁcantly lower 
in pts with genetic syndromes than those without (MDI: 86.4 ± 14.9 vs. 96.3 ± 8.5, p = 
0.017; PDI: 77.4 ± 19.2 vs. 90.0 ± 12.2, p = 0.019). Arch obstruction had no effect on MDI 
or PDI. By multivariate analysis, lower birth weight predicted worse PDI score (p = 0.006) 
and the presence of a conﬁrmed/suspected genetic syndrome predicted worse MDI score 
(p = 0.005). Age at surgery, coexisting arch obstruction and intraoperative support times 
were not predictive of outcome.
Conclusion: Neurodevelopmental outcome at one year of age was within the normal 
limits for most patients who underwent repair of a VSD or VSD with coarctation during 
infancy. Low birth weight and genetic syndromes were most predictive of lower scores. ND 
outcome at one year was independent of anatomic and intraoperative factors.
1114-245 Low Preoperative Cerebral Oxygen Saturation Predicts 
Perioperative Mortality In Children With Congenital 
Heart Disease
Kathleen N. Fenton, Kimberly Glogowski, Sherrie Fogg, Katherine Freeman, Kim F. 
Duncan, Children’s Hospital, Omaha, NE
Background: Recent studies in adults undergoing cardiac surgery indicate that monitoring 
the cerebral oxygen saturation (CSAT) predicts adverse neurologic events, and that 
making appropriate changes to correct low CSAT can improve outcome. Expected values 
for children with congenital heart disease have not been reported nor correlated with 
clinical outcome. 
Methods: CSAT was continuously recorded in 98 infants and children undergoing repair 
of congenital heart defects on cardiopulmonary bypass. Baseline CSAT was obtained prior 
to induction of anesthesia. Preoperative and postoperative saturations were correlated 
with the patients’ physiology and outcome.
Results: Patient age ranged from 2 days to 17 years. Mean CSAT was 63% at baseline 
and 65% postbypass (p=NS). CSAT was improved postoperatively in patients without 
residual left-to-right shunts (even if they were still cyanotic, Figure), but was lower 
postoperatively in patients undergoing Stage I palliation for single ventricle anatomy. 
Baseline CSAT was 41.8% in 4 patients with perioperative death compared to 63.5% in 
survivors (p<0.004).
Conclusions: Low baseline CSAT predicts perioperative mortality in children with 
congenital heart disease. Patients undergoing Stage I palliation have lower postoperative 
CSAT. Measurement of CSAT preoperatively will provide additional information for parent 
counseling, and preoperative optimization of cerebral oxygen saturation may improve 
outcome.
1114-246 Aortic Arch Obstruction is Associated With Low 
Preoperative CBF in Neonates with Severe Congenital 
Heart Defects
Daniel J. Licht, Jiongjiong Wang, David Silvestre, Erin O’Tool, Sarah Tabbut, Susan 
C. Nicolson, Lisa M. Montenegro, Suzanne Durning, David Shera, Rebecca Ichord, 
Gil Wernovsky, Thomas L. Spray, Robert A. Zimmerman, J. William Gaynor, Robert R. 
Clancy, John A. Detre, The Children’s Hospital of Philadelphia, Philadelphia, PA, The 
Hospital of the University of Pennsylvania, Philadelphia, PA
BACKGROUND: Poor neurocognitive outcome in survivors of early heart surgery has 
become a major focus for study as the survival rate from these surgeries increases. The 
hypothesis of this study is that preoperative cerebral blood ﬂow (CBF) is signiﬁcantly 
diminished in neonates with severe forms of CHD, and may be associated with aspects 
of the cardiac anatomy.
Methods: We measured CBF in infants with CHD utilizing a novel non-invasive MRI 
technique termed pulsed arterial spin label perfusion MRI (PASL-pMRI) which also allows 
for concurrent structural brain imaging. CBF measurements were made immediately 
before surgery, under standard ventilator settings (PaCO2 = 40.7 + 4.6 mmHg).
RESULTS: 60 term infants were studied, 32 were male, average weight 3.19 + 0.53 
kg (range 2.16 - 4.99), average gestational age 38.7 + 1.2 weeks, and average head 
circumference (HC) 33.7 + 1.6 cm (normal = 35cm). All patients were ventilated and 
sedated. Variations of 16 different CHD diagnoses were studied, including single ventricle 
physiology (n=33), with (n=30) or without (n=3) aortic arch obstruction. Hypoplastic left 
heart syndrome (HLHS, n=21) was the most common diagnosis. Baseline CBF for the 
entire cohort was 18.0 + 9.7 ml/100g/min, well below the expected 50 + 3.4 for term 
newborns and below the value (20ml/100g/min) reported as a conferring an increased risk 
for poor neurocognitive outcome. Fourteen infants (23%) had CBF below 10ml/100g/min, 
a level associated with moderate ischemic injury in a piglet model. Stepwise selection 
procedures identiﬁed the presence of aortic arch obstruction as predictive of lower 
baseline CBF (p = 0.008).
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CONCLUSSION: Pre-operative CBF in infants with complex CHD is low and may be an 
unrecognized risk factor for poor neurocognitive development. The presence of aortic arch 
obstruction was identiﬁed as being associated with low resting CBF.
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837-3 Quality of Life Assessment After Fontan Differs 
Between Children and Their Parents
Linda M. Lambert, L. LuAnn Minich, Margaret K. Harkins, Darlene Servedio, Nancy R. 
Slater, Ellen McGrath, Amy Jones, Ann Marie Nawrocki, Elizabeth Radojewski, Victoria 
Pemberton, Paul D. Mitchell, Lynn Mahony, Gail D. Pearson, Jane W. Newburger, 
Bernard J. Clark, Pediatric Heart Clinical Research Network, Watertown, MA
Background: Quality of life (QOL) assessments are often completed by parents rather 
than patients. As long-term Fontan survival improves, it is important to understand how 
child/parent perceptions differ.
Purposes: To compare child/parent QOL perceptions after Fontan and to determine if the 
child’s age or gender affects this comparison.
Methods: In the Pediatric Heart Network Fontan study, children aged 10 - 19 years were 
given the Child Health Questionnaire (CHQ-CF87) and parents were given the Parent Form 
(CHQ-PF50). Questions were identical in 7 domains and differed only by the number of items 
comprising the subscore in the remaining 6. Comparisons are based on paired differences 
(child - parent), which were normally distributed and tested by paired t-test and ANOVA.
Results: Of the 544 children enrolled, 352 were 10 - 19 years and 322 (91%) child/parent 
dyads completed the forms. Age was 13.9 ± 2.6 yrs, 60% were male, 153 (48%) were 
preadolescent. Child/parent scores were similar for global health, bodily pain/discomfort, 
global behavior, family activities, and family cohesion. In the remaining domains (Table) 
child scores were higher than parent scores. In 4/9 domains, the size and direction of 
parent-child differences depended on age. No gender interactions were found. 
Child-Parent Differences (mean ± SD, P value) 
Domain All Dyads Pre-adolescent Adolescent
Role/Social Limitations-Emotional 4.7 ± 27.8 0.003 4.7 ± 28.2 4.6 ± 28.1 0.99
Change in Health 0.4 ± 1.0 <0.001 0.4 ± 1.1 0.4 ± 1.1 0.81
Physical Functioning 2.9 ± 15.3 <0.001 0.7 ± 14.8 4.5 ± 14.9 0.02
Role/Social Limitations-Physical 4.3 ± 24.4 0.002 4.2 ± 23.7 5.6 ± 23.7 0.60
Behavior (getting along) 4.5 ± 15.5 <0.001 6.4 ± 14.7 2.8 ± 14.7 0.03
Mental Health 1.9 ± 14.5 0.02 3.5 ± 14.4 0.0 ± 14.4 0.03
Self Esteem 9.0 ± 16.7 <0.001 8.9 ± 17.0 9.1 ± 17.0 0.93
General Health Perceptions 12.8 ± 17.8 <0.001 14.3 ± 18.1 11.4 ± 18.1 0.16
Family Cohesion -2.4 ± 25.0 0.09 1.7 ± 23.1 -5.1 ± 23.2 0.01
Conclusion: Based on these differences between child/parent perceptions of QOL after 
Fontan, healthcare planning must include both child and parent to balance risk-taking 
behavior with avoidance of unnecessary restrictions.
8:45 a.m.
837-4 The Effect of Age, Diagnosis and Previous Surgery 
in 488 Children and Adults Who Undergo Heart 
Transplantation for Congenital Heart Disease
Jacqueline M. Lamour, Kirk R. Kanter, David C. Naftel, Maryanne R. Chrisant, W. Robert 
Morrow, Barry S. Clemson, James K. Kirklin, Columbia University/Babies Hospital, New 
York City, NY
Congenital heart disease (CHD) is considered a risk factor for mortality after heart 
transplantation (HT) yet this unique group represents a spectrum of complexity. We 
sought to identify risk factors for early and late mortality after HT for CHD in infants, 
children and adults. 
METHODS: There were 488 patients transplanted for CHD from the combined Pediatric 
Heart Transplant Study (1993-2002, n=367) and the Cardiac Transplant Registry Database 
(1990-2002, n=121). The age distribution at HT was 152 patients from 6mth to 6yr (31%), 
83 patients from 6yr to 12yr (17%), 139 patients from 12yr to 20yr (28%), and 113 patients 
>20yr (23%). The median age at HT was 12.4yrs; range 6mth to 62 yrs.
RESULTS: Primary HT diagnosis included: single ventricle (SV) (36%), d-transposition 
of the great arteries (TGA) (12%), right ventricular outﬂow tract lesions (RVOTO) (10%), l-
TGA (8%), ventricular/atrial septal defects (8%), LVOTO (8%), other (18%). The ﬁnal major 
operation prior to HT included palliative surgeries in SV pts including Bidirectional Glenn 
shunt (26%) and Fontan (48%). Overall survival post-HT was 80% at 1 year and 70% at 5 
years. By multi-variable analysis, risk factors for earlier mortality were older recipient age 
(p=.02), older donors with longer ischemic times (p =.0007), pre-HT Fontans (p=.003) and 
higher right atrial pressure (RAP) in patients without pre-HT Fontan (p<.0001). Predicted 
survival in Fontan patients was lower (77% and 70% at 1yr and 5yrs) vs. the non-Fontan 
patients (88% and 81% at 1yr and 5yrs). The effect of ischemic time was most prominent 
in donors above the age of 30 years. CONCLUSIONS: Patients transplanted for CHD 
have a good late survival especially if they survive the early post-operative period. The 
major operation prior to transplant is more predictive of survival than the actual congenital 
diagnosis with Fontan patients having a higher early mortality. When utilizing older donors 
(>30 years) for recipients with CHD, care should be taken to keep the ischemic time low 
in order to minimize early mortality.
9:00 a.m.
837-5 Gender-Related Disparity in Surgical Mortality Among 
Pediatric Patients Undergoing Cardiac Surgery
Ruey-Kang Chang, Sandra Rodriguez, Maggie Lee, Thomas Klitzner, David Geffen 
School of Medicine at UCLA, Los Angeles, CA, CA
Background: Little is known whether sex differences in cardiovascular outcomes found 
in adults also exist in children who undergo surgical repair for congenital heart disease.
Methods: Statewide hospital discharge data from California in 1989-1999 were used. 
Children <18 years who had a procedure code (by ICD9-CM) indicating cardiac surgery 
were selected. The outcome variable was in-hospital death. Cardiac surgical procedures 
were grouped into 23 categories to adjust for risk involved with the procedures. Hospitals 
were divided into low (≤100 cases/year) and high volume hospitals (>100 cases/year). We 
used logistic regression to evaluate the effect of gender on in-hospital mortality controlling 
for age, race and ethnicity, type of insurance, home income, date and month of surgery, 
type of admission, hospitals case volume and various types of procedures.
Results: There were 25,402 cardiac surgery cases with 1505 in-hospital deaths, and 49 
out-of-hospital deaths within 30 days, yielding a mortality rate of 6.12%. Crude mortality 
rates for males (6.18%) and females (6.04%) were not signiﬁcantly different. However the 
females group had fewer neonatal operations and had more low risk procedures than 
males. Logistic regression showed that females, compared to males, had a signiﬁcantly 
higher odds ratio (OR) for in-hospital mortality (OR=1.18, p<0.01) and overall (up to 30 
days post-discharge) mortality (OR=1.19, p<0.01). The odds ratio for mortality was 2.28 
for neonates and 1.82 for infants when compared with children >1 year. Low volume 
hospitals had higher mortality than high volume hospitals (OR=1.26). The risk adjusted 
length of hospital stay was similar between females and males.
Conclusions: Female sex is associated with an 18% higher in-hospital and 30-day mortality 
than male sex. There was no difference in length of hospital stay between males and females. 
The mechanism by which female sex acts as a risk factor requires further investigation.
9:15 a.m.
837-6 U.S. Multicenter Pivotal Study of the HELEX Septal 
Occluder
Thomas K. Jones, Thomas E. Fagan, Evan M. Zahn, Joth L. Jacobson, Larry A. Latson, 
for the HELEX Septal Occluder U.S. Pivotal Study Investigators, Children’s Hosp. & 
Regional Medical Center, Seattle, WA
Background: The HELEXtm Septal Occluder (HSO) is a low proﬁle, double disk occluder 
device for percutaneous closure of secundum atrial septal defect (ASD). This study 
compares the safety and efﬁcacy of the HSO to surgical repair of ASD.
Methods: Patients were enrolled (HSO arm prospectively; surgery arm prospectively/
retrospectively) from 14 US sites and followed for 12 months post procedure. Investigator-
repored outcomes were evaluated including clinical success (no or clinically insigniﬁcant 
residual shunt) and the incidence of adverse events (AE). The ﬁrst 3 HSO pts at each site 
were considered training cases and excluded from analysis.
Results: Between 3/01 and 4/03, 132 non-training cases received a HSO and 124 
had surgical repair. The groups were similar with statistical but clinically unimportant 
































p value - .019 <.001 <.001 <.001 <.001 .110 .888 .505
Anesthesia time and hospital stay were signiﬁcantly shorter in the HSO group. Success, 
deﬁned as complete closure or a clinically insigniﬁcant residual shunt, was similar in both 
groups. Major and minor AE rates were not statistically different. The most common major 
AE for the HSO group was device embolization requiring catheter retreival (3) and for the 
surgery group post pericardiotomy syndrome (8) including one death due to tamponde.
Conclusions: Closure of ASD with the HELEXtm Septal Occluder compares favorably to 
surgical repair with reduced anesthesia time and hospital stay.
9:30 a.m.
837-7 Short Term Complications of Branch Pulmonary Artery 
Stenting: a Multicenter Study
Maarten Witsenburg, Marc Gewillig, Menno Van Gameren, Mathias Freund, Regina 
Bokenkamp, Daniel De Wolf, Anton Van Oort, Melle Talsma, Hanneke Takkenberg, 
ErasmusMC-Sophia Children’s Hospital, Rotterdam, The Netherlands, University 
Hospital Gasthuisberg, Leuven, Belgium
Background: Although stenting for branch pulmonary artery (PA) stenosis is widely 
accepted, little is known about the risks involved in this procedure. A retrospective 
multicenter study in 7 centers in The Netherlands and Belgium was performed to uncover 
short term complications.
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Methods: 156 patients (89 male, 67 female) received 235 stents in 223 (left 129; right 
94) PA’s during 185 cardiac catherizations. Mean patient age was 8,9 yrs (range 0.1-
51). Mean weight was 28.8kgs (4-80). Complications were divided into major and minor. 
Minor complications include all transient unanticipated events, including inappropriate 
stent positioning. Major complications include all events leading to death, life threatening 
hemodynamic compromise, need for surgical intervention or signiﬁcant permanent 
anatomic or functional lesion. Unmounted stents were used in 143 sites, premounted in 
67 sites, self-expanding in 7 and in 6 stent type was unknown.
Results: 2 patients (1.3%) died, one of pulmonary edema and one of coronary ischemia. 
Site related complications occurred in 37/223 sites (16,6 %), in 14/223 sites (6.3%) 
these were major. Malposition/migration/embolization occured in 18 sites (7/18 major); 
unreached sites 8 sites (2/8 major); balloon ruptures 6 sites (1/6 major); pulmonary 
edema 2 sites (2/2 major); dissection 1 site (1/1 major); arrhytmia 1 (no major); coronary 
ischemia 1site (1/1 major). Complication rates were not different between native and post 
surgery stenoses, nor between age <1yr and older pts. Complications (total and major) 
were signiﬁcantly lower with premounted stents, although the age in both groups was not 
comparable. Center experience in yrs was not related to complication rate.
Conclusions: Although major complication rate is low, short term complication rates of 
branch PA stenting should not be underestimated. Stent migration/embolization occur 
in about 10%. Premounted stents have lower complication rates, and should become 
available in larger diameters with the option to dilate them above the nominal value.
9:45 a.m.
837-8 Cardiac Complications During Pregnancy In 
Atrioventricular Septal Defect Patients.
Willem Drenthen, Karin van der Tuuk, Els Pieper, Bianca Mostert, Vincent van Dijk, 
Adriaan Voors, Jolien Roos-Hesselink, Tjark Ebels, Dirk J. van Veldhuisen, on behalf 
of ZAHARA investigators, University Hospital Groningen, Groningen, The Netherlands, 
Erasmus Medical Centre, Rotterdam, The Netherlands
Background: Limited information is available about potential complications during 
pregnancy in atrioventricular septal defects (AVSD).
Methods: From the nation-wide Congenital Corvitia (CONCOR) registry female patients 
with AVSD were enrolled. Detailed recordings of each pregnancy were obtained after 
receiving written informed consent.
Results: 79 AVSD (18 common oriﬁce, 65 repaired) patients, including 17 with Down 
syndrome, were enrolled. Sixty-two pregnancies were observed including 12 miscarriages 
and 2 elective abortion. In the 48 completed pregnancies (>20 weeks of gestation, 26 
women; 48 children) the following maternal clinically signiﬁcant cardiac complications 
were recorded: arrhythmia (n=9); heart failure (n=1); endocarditis (n=1, postpartum); 
NYHA class deterioration (n=29, which persisted postpartum after 11 gestations) and 
deterioration of left/ right AV valve regurgitation (n=8 / 6; respectively). Arrhythmia 
during pregnancy was related to a history of arrhythmia, and NYHA class deterioration 
was associated with a residual ASD. Deterioration left/ right AV valve regurgitation was 
only seen in the patients with pre-existing regurgitation. Non-cardiac events included 
gestational hypertension (n= 7) and preeclampsia (n= 1). Assisted delivery (forceps n=5, 
vacuum n=4, caesarean sections n=7) were necessary in 33% of pregnancies, which is 
high compared to the general Dutch population. Congenital defects recurred in 6 patients: 
AVSD associated with left sided hypoplasia (n=3), AVSD (n=1), persistent ductus artriosus 
(n=1) and ostium primum or secundum ASD (n=1).
Conclusion: In this largest report, so far, we found a high incidence of clinical signiﬁcant 
maternal and foetal complications during pregnancy in AVSD patients.
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1142-237 Conditional Deletion Of Tbx1 Provides Insights Into The 
Pathogenesis Of Aortic Arch Abnormalities 
Fabiana Cerrato, Huansheng Xu, Masae Morishima, Antonio Baldini, Elizabeth Lindsay, 
Baylor College of Medicine, Houston, TX
BACKGROUND: Di George syndrome(DGS) is a relatively frequent genetic disorder 
caused by an interstitial heterozygous deletion of 22q11.2. DGS is characterized by aortic 
arch and conotruncal defects, thymus and parathyroid aplasia/hypoplasia and craniofacial 
anomalies. Genetic manipulation in the mouse and mutational analysis in patients have 
shown that Tbx1, a T-box transcription factor has a key role in the pathogenesis of DGS. In 
mice Tbx1 haploinsufﬁciency causes hypoplasia of the 4th pharyngeal arch arteries(PAA), 
while Tbx1 loss of function prevents formation of the caudal pharyngeal arches and arch 
arteries (III-VI). The embryonic PAAs are later remodelled to form speciﬁc segments of 
the great vessels. Our goal is to understand in which tissue Tbx1 function is important for 
cardiovascular development. For this we are using a Cre/loxP recombination system. The 
cre mutants allow us to delete Tbx1 expression in a tissue speciﬁc way in order to dissect 
Tbx1 function in pharyngeal development.
METHODS: Here we have tested two Cre mutants: Nkx2.5cre and Foxg1cre, both of which 
have cre-induced recombination patterns that partially overlap with Tbx1 expression. The 
latter drives more extensive recombination in pharyngeal epithelia than NKx2.5cre.
RESULTS: Nkx2.5cre-driven deletion of Tbx1 results in severe outﬂow tract (OFT) defects 
like Tbx1 null mice, but a milder pharyngeal phenotype, in that the caudal arches develop 
apparently normally. In contrast, Foxg1cre-driven deletion of Tbx1 results in severe OFT and 
aortic arch defects that are indistinguishable from those of Tbx1 homozygous mutants.
Comparison of Tbx1 expression with that of the cre drivers shows the difference between 
Foxg1cre- and Nkx2.5cre-induced deletion to be largely conﬁned to the pharyngeal 
epithelia, (pharyngeal endoderm and ectoderm) while both drivers are expected to ablate 
Tbx1 expression in the core mesoderm of the pharyngeal arches and in the secondary 
heart ﬁeld.
CONCLUSION: These results strongly suggest that expression of Tbx1 in pharyngeal 
epithelia is required for PAA formation.
1142-238 Intramyocardial Expression Of Cardiotrophin-1 In 
Infants With Congenital Cardiac Defects
Qing Ma, Kathrin Schumacher, Edith Wehage, Magda Sokalska, Flex Haas, Marie 
Christine Seghaye, Aachen University of Technology, Aachen, Germany, German Heart 
Center Munich, Munich, Germany
Background and aim: Expression of cardiotrophin-1 (CT-1) induced by hypoxia and/or 
hemodynamic overload results in myocardial hypertrophy. The hypertrophic response to 
CT-1 involves the Jak/STAT pathway while protective effects to the myocardium are related 
to the inducion of HSPs via the ERK1/2 MAP kinase pathway. Our study was desiged to 
clarify whether CT-1 is differentially expressed in infants with congenital cardiac defects.
Methods: Fifteen infants with tetralogy of Fallot (TOF) (n=7) or with ventricular septum 
defect (VSD) (n=8) were enrolled. The gene- and/or protein expression of CT-1, HSP70, 
and HSP90 were detected by real-time PCR and /or Western blotting in the right atrial 
(RA) and right ventricular myocardium (RV) taken before and during cardiac surgery. 
Levels of phospho-STAT3, phospho-ERK1/2 MAPK, and cleavage of caspase-3 were 
assessed by Western blotting.
Results: Expression of CT-1, HSP70, and HSP90 was detected in all patients at mRNA 
and /or protein level. Concentrations of CT-1 were higher in patients with TOF than in those 
with VSD (p<0.05). Considering all patients, concentrations of CT-1 inversely correlated 
with arterial oxygen saturation (Spearman: -0.57, p<0.03). Levels of of phospho-STAT3 
and ERK1/2 MAP kinase were not different between groups. Levels of HSP90 but not 
HSP70 were signiﬁcantly higher in infants with TOF than in those with VSD (p<0.05). 
Cleavage of caspase-3 was not detected in the myocardium of any patients.
Conclusions: Our results show for the ﬁrst time that CT-1 is differentially expressed in 
the myocardium of infants with congenital cardiac defects. Over-expression of CT-1 may 
contribute to myocyte hypertrophy via the Jak/STAT pathway. Additionally, over-expression 
of CT-1 before CPB as detected in RA may play a protective role by upregulating HSPs 
and by preventing the activation of caspase-3 and hereby reducing apoptosis via ERK1/2 
MAPK pathway.
1142-245 Rapid Screening of Complex Genetic Disorders 
Associated with Heart Disease Using Direct Whole 
Blood RT-PCR
Todd E. Miller, Lijing You, Paul J. Benke, Nanette Bishopric, University of Miami School 
of Medicine, Miami, FL
Background: Signiﬁcant problems limit the feasibility of genetic screening for many 
inherited cardiovascular diseases. Affected patients are often adults, necessitating large 
families for linkage analysis. Disorders such as hypertrophic cardiomyopathy (HCM) and 
Long QT Syndrome (LQTS) are associated with multiple genes, and many of these genes 
are very large, with more than 15 exons. Furthermore, these disorders are characterized 
by multiple missense and nonsense mutations that are scattered throughout the coding 
sequences rather than localizing to “hot spots”. Traditional exon-based approaches are 
costly and time consuming, and although RNA ampliﬁcation has been successfully 
applied in some cases, it has not been used for genotyping or screening because of the 
difﬁculty in amplifying cardiac-speciﬁc coding sequences from non-cardiac tissue and/or 
the need to perform cell culture to obtain sufﬁcient mRNA. 
Methods: To provide a comprehensive solution to this problem and enable wider 
genetic screening, we have employed a new sample collection method that optimizes the 
preservation of whole blood RNA templates for RT-PCR. Using this method we have been 
able to directly sequence mRNA transcripts of KCNQ1, KCNH2, KCNE1, KCNE2 and 
KCNJ2 (LQTS), MYBPC3 (HCM), LMNA and TAZ (dilated cardiomyopathy) and FBN1 
(Marfan Syndrome) from peripheral blood. For example, a complete coding sequence 
screen for mutations in FBN1, a 300 kb gene with 65 exons and a coding sequence of 
8.5 kb, can be completed in 2 days using 14 PCR primer pairs. Results: To date we have 
screened 24 samples from 20 patients and 4 controls. We have detected a total of 29 
heterozygous SNPs in the primary RNA sequences. All were conﬁrmed in subsequent 
genomic sequencing. We have also identiﬁed 3 mutations in KCNQ1 (T144A, F339S, 
R594P), 2 in FBN1 (4904/5delC, 6354C>T which leads to deletion of exon 51), a splicing 
mutation in TAZ (238G>A), and a previously identiﬁed mutation in MYBPC3 (R502Q). 
Conclusions: These results demonstrate the feasibility of high-throughput screening for 
inherited cardiovascular genetic disorders in patients of all ages. We anticipate that this 
method may be extended to other genes of interest.
1142-246 Localization of Dendritic Cells and Monocytes to the 
Graft Matrix of Polytetraﬂuoroethylene Grafts Used in 
the Palliation of Cyanotic Heart Defects
John L. Jefferies, Debra L. Kearney, Charles D. Fraser, E. Dean McKenzie, Antonio R. 
Mott, Baylor College of Medicine, Houston, TX
Background: Polytetraﬂuoroethylene (PTFE) grafts, commonly used in the creation of 
aortopulmonary shunts (APS), may have compromised blood ﬂow due to neointimal 
proliferation (NIP). Smooth muscle cells (SMC) are the predominant cells of NIP in 
native arteries and bypass grafts however recent studies challenge the traditional 
dogma of origin of the SMC from the native vessel wall. Other postulated sources 
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include transdifferentiation of circulating monocytes, bone marrow stem cells, and tissue 
macrophage/dendritic cells. Study populations have included adults and experimental 
animal models. We describe the cellular histologic proﬁle of APS placed in infants.
Methods: The surgically excised distal end of the APS was formalin ﬁxed/processed by 
routine histologic techniques for light microscopy. Routine H & E sections were examined 
as well as immunohistochemical stains for lymphocytes (Pan T and Pan B), macrophages 
(KP-1), dendritic cells (HLADr, S-100) and smooth muscle actin.
Results: Twenty-ﬁve APS were explanted from 25 infants who were undergoing Glenn 
shunt placement (n=23) and repair of tetralogy of Fallot (n=2). The mean age at surgery 
was 1.02 months and mean elapsed time from APS placement to its explantation was 
7.97 months.
NIP, expressed as % of graft wall thickness, ranged from mild (30%) to marked (400%), 
and was generally eccentric. SMC, were present in the intima of all but one APS, with 
scattered cells evident in the graft matrix in 80%. Other than SMC, APS cellularity was 
most prominent in the graft matrix. All 25 APS had HLADr + cells in the matrix (striking 
in 88%). Most were not dendritic cells (mild S-100 matrix staining in 64% APS) or 
macrophages (predominantly mild KP-1 matrix staining in 88% APS). Dendritic cells 
were more frequently seen in the perigraft neoadventitia than in the neointima. Rare T 
lymphocytes generally co-localized with macrophages.
Conclusion The graft matrix of PTFE APS is the primary location for macrophages, 
dendritic cells and a population of HLADr + cells which may represent monocytes, and/or 
bone marrow stem cells. Cellular interactions at this site with possible participation by 
adventitial dendritic cells may contribute to the pathogenesis of NIP.
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1143-239 Central Pulmonary Artery Growth After Central Shunt 
Placement in Patients With Pulmonary Atresia and 
Ventricular Septal Defect With Severe Pulmonary Artery 
Hypoplasia
Brandy A. Kashyap, Mark W. Turrentine, Robert K. Darragh, Marcus S. Schamberger, 
Indiana University School of Medicine, Indianapolis, IN
Background: Various surgical approaches have been designed to promote pulmonary 
artery (PA) growth in pulmonary atresia. However, patients with severely hypoplastic 
pulmonary arteries (< 3mm) may not be candidates for traditional palliation. Our approach 
is to place a central shunt from the aorta to the hypoplastic main pulmonary segment. This 
promotes uniform proximal and central PA growth while maintaining RV-PA continuity for 
future transannular repair.
Methods: Nine pts. with pulmonary atresia and ventricular septal defect (VSD) with 
severely hypoplastic PA (HPA) underwent placement of an aorto-pulmonary central 
shunt by the same surgeon from 1996 to 2003. Pulmonary artery growth measurements 
were performed on angiograms at different stages of repair and standardized using the 
McGoon and Nakata indices. The McGoon ratio is calculated from the diameter of the 
pulmonary arteries divided by the diameter of the descending aorta (DRPA(mm) + DLPA(mm)/
DAorta(mm)). A normal ratio is >2; a ratio of < 0.8 indicates severely HPA. The Nakata index 
is calculated by indexing the cross-sectional area of pulmonary arteries to body surface 
area (CSARPA(mm) + CSALPA(mm)/BSA(m)). A normal index is 330+30 mm
2/m2; an index <150 
mm2/m2 indicates HPA.
Results: All patients are currently alive with a mean follow-up of 4.7 + 2.2 years. The 
right pulmonary artery increased in size from an average of 1.6 + 1.0 mm to 8.2 + 1.6 
mm (p<0.0001). The left pulmonary artery increased from 1.4 + 0.7 mm to 8.3 + 2.5 
mm (p<0.0001). The McGoon ratio increased signiﬁcantly from an initial value of 0.6 to 
2.0 (p<0.0003) indicating normalization of PA size. Similarly, the Nakata index increased 
from 18.5 mm2/m2 to 211.3 mm2/m2 (p<0.0001). Eight pts. (89%) had sufﬁcient pulmonary 
artery growth for an RV-PA outﬂow patch placement; one pt. is awaiting surgery. Six pts. 
(75%) have undergone a full repair with VSD closure at an average age of 1.7 + 0.6 years; 
three of the six had fenestrated VSD closures. Two pts. await full repair.
Conclusion: Central shunt placement in pts.with severely hypoplastic pulmonary arteries 
(<3mm) provides central pulmonary ﬂow and results in growth of the native pulmonary 
arteries allowing for eventual transanular repair.
1143-240 Negative Impact on Survival of Infants with Mitral Valve 
Patency and Aortic Valve Atresia in Hypoplastic Left 
Heart Syndrome
Raymond T. Fedderly, Jenifer A. Glatz, Kathleen A. Mussatto, Nancy S. Ghanayem, 
Matthew C. Scanlon, Jingnan Mao, Robert Jaquiss, James S. Tweddell, Medical College 
of Wisconsin, Milwaukee, WI
Background: Despite recent improvement in survival of infants with hypoplastic left 
heart syndrome (HLHS), mortality occurs both perioperatively and during follow-up. Our 
hypothesis is that the presence of a left ventricle (LV) with a patent mitral valve (MV) and 
aortic valve (AoV) atresia negatively impacts survival of infants with HLHS after staged 
palliation.
Methods: All patients (n=72) with classic HLHS born between 8/96 and 5/02 who 
underwent stage I palliation at the Children’s Hospital of Wisconsin had presenting 
echocardiograms reviewed for an identiﬁable LV cavity and patency of the MV and AoV. 
The patients were divided into 3 groups: AoV atresia/MV atresia (AA/MA), AoV patent/MV 
patent (AS/MS), and AoV atresia/MV patent (AA/MS). Chi-square test, t-test and Wilcoxon 
Score test were used for analysis. Actual survival analysis was done using Kaplan-Meier 
method with Log Rank test.
Results: Of the 72 patients, 75% had AoV atresia and 44% had a patent MV. AoV 
atresia alone was not associated with increased mortality, however when AoV atresia 
was combined with a patent MV, mortality was increased (p<0.05). The groups, AA/MA 
(n=39), AS/MS (n=17), and AA/MS (n=16), did not differ in age or weight at the time of 
stage I palliation. The 30 day survival of all patients was 97% and the overall mortality to 
date is 21%. Thirty day survival was 100% in AA/MA, 100% in AS/MS, and 88% in AA/MS 
(AA/MS < AA/MA, p<0.05). Survival to stage II palliation was 95% in AA/MA, 94% in AS/
MS, and 56% in AA/MS (p<0.05 for AA/MS < AA/MA or AS/MS). Mortality to date is 13% 
in AA/MA, 18% in AS/MS, and 44% in AA/MS (p AA/MA or AS/MS).
Conclusion: AoV atresia was associated with increased mortality only in the presence 
of a patent MV. A LV with AoV atresia and a patent MV negatively impacted the survival of 
patients with HLHS as seen in 30 day survival, survival to stage II palliation, and mortality 
to date.
1143-241 NGAL: A Novel Early Biomarker of Renal Injury 
Following Cardiac Surgery
Catherine L. Dent, Ridwan Tarabishi, Jaya Mishra, Qing Ma, Tracey VanVliet, Lois 
Bogenschutz, Mark Mitsnefes, Prasad Devarajan, Cincinnati Children’s Hospital Medical 
Center, Cincinnati, OH
Background: Acute ischemic renal failure (ARF) is common after cardiac surgery and 
is associated with high mortality. The lack of early biomarkers for ARF limits our ability 
to initiate effective therapy to improve renal function. We have shown that neutrophil 
gelatinase-associated lipocalin (NGAL) is maximally induced early in post-ischemic 
transplanted kidneys. In this study, we tested the hypothesis that NGAL is an early 
biomarker for ARF after cardiopulmonary bypass (CPB).
Methods: We enrolled 45 pediatric patients undergoing CPB. Exclusion criteria were 
pre-existing renal dysfunction and use of nephrotoxic agents. Serum and urine were 
collected at baseline and at frequent intervals for 5d after CPB and analyzed for NGAL 
by semi-quantitative Western blot and quantitative ELISA. NGAL was easily detectable 
and comparable by both methods. The primary outcome was ARF (a ≥50% increase in 
serum creatinine).
Results: Ten patients (22%) developed ARF 24-72h after CPB. Patients without ARF had 
a small rise in NGAL which normalized within 1d. In contrast, ARF patients had a marked 
increase in urine and serum NGAL, evident in the very ﬁrst urine after CPB and persisting 
throughout the study. In ARF patients, there was a signiﬁcant correlation between CPB 
time and peak urinary NGAL (p<0.05, r=0.65).
Conclusion: As a sensitive urine and serum biomarker, NGAL allows very early diagnosis 
of ARF after CPB. Early treatment of ARF after CPB could signiﬁcantly improve outcome 
in high-risk patients. 















ARF (n=10) 2±1 103±15* 85±20* 71±15* 2±1 53±7* 44±11*
Non-ARF (n=35) 2±1 7±3 8±3 6±3 5±2 9±3 4±2
*p<0.05 vs non-ARF
1143-242 Improvement of Spatial QRS-T Angle after Pulmonary 
Valve Replacement in Tetralogy of Fallot
Bart Hooft van Huysduynen, Cees A. Swenne, Henk J. Ritsema van Eck, Arie C. 
Maan, Alexander van Straten, Martin J. Schalij, Ernst E. van der Wall, Albert de Roos, 
Mark G. Hazekamp, Hubert W. Vliegen, Leiden University Medical Center, Leiden, The 
Netherlands
Background. Right ventricular failure caused by pulmonary valve regurgitation is a 
common complication late after total repair of Fallot’s tetralogy. In these patients, electrical 
abnormalities and repolarization disturbances are associated with ventricular arrhythmias 
and sudden cardiac death. In the present study we assessed whether pulmonary valve 
replacement (PVR) not only leads to reversed remodeling of the right ventricle but also to 
beneﬁcial electrical changes. We measured the spatial angle between the QRS complex 
and T-wave before and after PVR. This electrocardiographic index has been proposed 
to charactarize global repolarization heterogeneity and has prognostic value in healthy 
subjects and patient groups.
Methods. 26 adult Fallot patients (age 30 ± 9 year, 15 male) eligible for PVR were studied 
with cardiac MRI before and 6 months after PVR. ECGs closest in time to these MRIs 
were analyzed with a customized ECG program. The QRST complexes were averaged 
and the intervals were measured by a blinded observer. Spatial angles were automatically 
calculated from the vectorcardiogram generated with the inverse Dower matrix.
Results. Cardiac MRI showed a RV end-diastolic volume decrease from 305 ± 87 to 210 
± 62 mL, P<0.001. The spatial angle between the QRS complex and T-wave decreased 
from 116 ± 30° to 95 ± 35°, P<0.001 (normal angle < 105°).
Conclusion. PVR reduces RV end-diastolic volume and decreases the spatial QRS-T 
angle from an abnormally high value to a normal, smaller value. PVR in Fallot patients 
with failing right ventricles not only reduces RV dimensions but also leads to beneﬁcial 
electrical effects.
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845-3 Exercise Intolerance in Adult Congenital Heart Disease 
Patients is Comparable to Older Non-Congenital Heart 
Failure Patients, Relates to Underlying Cardiac Defects 
and Predicts Hospitalization-Free Survival
Gerhard-Paul Diller, Darlington O. Okonko, Konstantinos Dimopoulos, Stephanie Bayne, 
Sonya Babu-Narayan, Craig S. Broberg, Isabelle F. Vonder Muhll, Beatriz Bouzas, 
Michael A. Gatzoulis, Adult Congenital Heart Disease Programme, Royal Brompton 
Hospital, London, United Kingdom, National Heart and Lung Institute, Imperial College 
London, London, United Kingdom
Background- Exercise intolerance is ubiquitous in adult congenital heart disease (ACHD), 
but little is known about its comparative severity, its determining factors and prognostic 
implications across the spectrum of contemporary patients with ACHD.
Methods - Cardiopulmonary exercise tests were performed in 335 consecutive ACHD 
patients (age 33.1±12.7 y, NYHA 1.6±0.7) with varying diagnoses, 40 heart failure (HF) 
patients (age 57.8±15.3 y, NYHA 2.2±0.8), 12 old (age 53.9±7.4 y) and 9 young (age 
29.5±5.8) healthy controls.
Results - Peak oxygen consumption (pVO2) was reduced in ACHD patients compared 
to young controls (controls 46.3±8.6, patients: NYHA I 26.1±8.2, NYHA II 18.5±6.8, 
NYHA III 15.2±4.5 ml/kg/min; p<0.0001). In contrast, no signiﬁcant difference in pVO2 
was found between ACHD and NYHA-matched HF patients. Within ACHD groups pVO2 
gradually declined from aortic coarctation (28.7±10.4) to Eisenmenger (11.5±3.6) patients 
(p<0.0001). On simple regression analysis peak heart rate (r=0.494), diagnosis (r=0.488), 
cyanosis (r=0.408), age (r=-0.381), age at surgery (r=-0.301), gender (r=-0.279), systemic 
ventricular function (r=-0.189), pulmonary ventricular function (r=-0.179), sodium (r=0.161) 
and body mass index (r=-0.128) related to pVO2 (all p<0.02). On multiple regression, peak 
heart rate (r=0.364), gender (r=-0.336), body mass index (r=-0.317), diagnosis (r=0.216) 
and cyanosis (r=-0.181) remained related to pVO2. During follow-up (9.2±4.0 months), 
61(18.2%) patients died or were hospitalized. On multivariate cox analysis pVO2 predicted 
hospitalization-free survival (HR=0.923, p<0.0001) independently of NYHA, sodium, 
peak pulse and diagnosis. On multiple regression analysis pVO2 was also independently 
related to the frequency (p=0.03) and duration (p=0.006) of hospitalization.
Conclusions - Exercise intolerance in ACHD gradually worsens from patients with simple 
to complex cardiac lesions, is comparable to older non-congenital heart failure patients 
and is associated with an ampliﬁed risk of death or hospitalization. Therapeutic strategies 
that increment exercise capacity in ACHD may confer prognostic beneﬁts.
10:45 a.m.
845-4 Is Exercise Training Beneﬁcial In Adults With Congenital 
Heart Disease?
Jaspal Singh Dua, Alan Graham Stuart, Ashley R. Cooper, Kenneth Richard Fox, Bristol 
Heart Institute, Bristol, United Kingdom, University of Bristol, Bristol, United Kingdom
Background: A wide range of health beneﬁts are associated with regular exercise 
training but its inﬂuence on exercise capacity & quality of life in adults with congenital 
heart disease (CHD) has not been fully investigated.
Methods: 56 patients were recruited & divided into 3 subgroups depending upon their 
NYHA class. Exercise capacity was determined by treadmill walking. Quality of life was 
ascertained using four questionnaires: Physical Activity Questionnaire (PAQ), Diener’s 
Satisfaction with Life Questionnaire (DSLQ), Physical Self-Perception Proﬁle (PSPPs) 
and Health Survey (SF-12). Accelerometers were used to measure baseline energy 
expenditure. These data were used to devise an individualised incremental 10-week 
exercise regimen consisting of walking for 5 days/week, with weekly increases in walking 
time. Assessment was repeated after 10 weeks.
Results: 22 patients (mean age 33.5 ± 10.8 yrs; 12male) have completed the study 
measures so far. Treadmill walking time increased from a mean of 8.6 minutes to 10.9 
minutes [p< .0001]. Mean questionnaire scores of all four questionnaires increased after 
training implying improvement in quality of life, physical self-perception and perceived 
health status (Table). 
n=22 Treadmill Duration (in minutes)
Activity Linked 
Energy Expenditure 
in 7 Days (Calories)
PAQ Score PSPPs Score DSLQ Score Health Survey SF-12 Score
Before After Before After Before After Before After Before After Before After
Min 1.02 2.01 1134 1540 27 44 20 22 16 16 20 24
Max 16.20 19.28 3700 5611 81 83 66 67 33 35 47 45
Mean 8.6 10.87 1835 2533 56.7 63.5 47.9 50.4 25.3 28.0 33.5 37.5
‘p’ value <.0001 <.0002 <.013 <.12 <.0005 <.0005
Conclusions: A simple physical activity intervention is effective in signiﬁcantly increasing 
the exercise capacity of adults with CHD and improves the quality of life by improving 
physical self-perception, satisfaction with life and general health.
11:00 a.m.
845-5 Iron Deﬁciency in Adult Patients with Cyanotic 
Congenital Heart Disease does Not Increase Blood 
Viscosity
Craig S. Broberg, Bridget Bax, Darlington O. Okonko, Arif Khan, John Burman, Michael 
A. Gatzoulis, Royal Brompton Hospital & Hareﬁeld NHS Trust, London, United Kingdom, 
St. George’s Hospital, London, United Kingdom
Background: The understanding that low iron in patients with cyanotic congenital heart 
disease leads to microcytosis and hyperviscosity is based on studies that are inconsistent 
and not universally applicable to this population. We sought to clarify the relationship 
between available iron, viscosity, exertional tolerance, and symptoms.
Methods: Adults with cyanotic congenital heart disease were asked to rank (0-3 scale) the 
severity of 12 common hyperviscosity symptoms, and to perform a 6-minute walk test. Whole 
blood viscosity and plasma viscosity were measured using a Contraves LS 30 rotational 
viscometer at 37°C over a range of shear rates (0.277 s -128.5 s), and remeasured after 
cells were reconstituted with autologous plasma to a hematocrit (Hct) of 45%. Hemoglobin 
(Hgb), Hct and full iron studies were measured on the same blood sample. All data were 
obtained within a 24 hour period. Results are expressed as mean ± SD.
Results: Of 22 patients studied, 8 (36%) were identiﬁed as having insufﬁcient iron for 
erythropoiesis based on transferrin saturation (<20%). This group had lower oxygen 
saturation (76 ± 7 vs. 83 ± 5%, p=0.009), Hgb (17.5 ± 1.1 vs. 20.6 ± 2.6 g/dl, p=0.001), 
mean corpuscular volume (MCV, 86 ± 9 vs 93 ± 4 ﬂ, p=0.027), mean corpuscular Hgb 
concentration (30.9 ± 1.2 vs. 32.6 ± 0.9 g/dl, p=0.001) and 6-minute walk distance (242 
± 164 vs. 376 ± 121 m, p=0.048). However, viscosity was not different, including that of 
whole blood, reconstituted cells at Hct 45% (all shear rates), and plasma. Furthermore, 
viscosity symptoms were common in all patients (most frequently fatigue and headache). 
No difference in any symptom score was found. Overall viscosity correlated strongly with 
Hct (R=0.658, p=0.001 at low shear and R=0.874, p<0.001 at high shear), but not with 
MCV (R2<1, range 72-100 ﬂ).
Conclusion: In adults with cyanotic heart disease, viscosity is dependent on Hct and not 
on iron levels or MCV. Symptoms often attributed to high viscosity are common in these 
patients, irrespective of Hct. Those with low iron have inadequate erythropoiesis, and 
thus some symptoms, including low exertional tolerance, may be related to insufﬁcient 
systemic oxygen transport rather than hyperviscosity.
11:15 a.m.
845-6 Chronotropic Incompetence in Adult Patients with 
Systemic Right Ventricle and Univentricular Circulation
Gerhard-Paul Diller, Darlington O. Okonko, Stephan von Haehling, Stefan Anker, Michael 
A. Gatzoulis, Adult Congenital Heart Disease Programme, Royal Brompton Hospital, 
London, United Kingdom, National Heart and Lung Institute, Imperial College London, 
London, United Kingdom
Background: Exercise limitation is common in patients with a systemic right ventricle 
or univentricular circulation. Inadequate heart rate response to exercise may be a 
contributing factor. We assessed the relationship between chronotropic incompetence 
(CI) and exercise capacity in a cohort of adult congenital heart disease patients who 
frequently require pacemakers.
Methods: We analysed consecutive cardiopulmonary exercise tests in patients with 
transposition of the great arteries (TGA) after atrial switch operation (n=21; m=15; age 
30.4±12.1 y), congenitally corrected TGA (n=12; m=9; age 33.3±12.8 y) and in patients 
after Fontan palliation (n=31; m=15; age 26.8±10.9 y). Chronotropic incompetence was 
deﬁned as the inability to reach 80% of the age predicted maximal heart rate (220-age).
Results: The frequency of CI was 64% in Fontan-patients, 58% in congenitally corrected 
TGA patients, and 33% in TGA patients (NS). Patients with CI had a shorter exercise time 
(561±172 vs 721±155 s, p<0.0001) and a lower peak oxygen consumption (18.7±4.9 
vs 23.5±6.3 ml/kg/min, p<0.001) compared with those without CI. The frequency of CI 
increased with disease severity (43% of NYHA I, 54% of NYHA II, and 100% of NYHA 
III, p=0.04). In univariate regression analysis peak oxygen consumption was related to 
NYHA class (r=0.53, p<0.001), maximal heart rate (r=0.412, p<0.001) and age (r=-0.356, 
p=0.004). On multivariate analysis only NYHA class (r=0.441, F=15.2) and peak heart 
rate (r=0.242, F=4.6) independently predicted peak oxygen consumption.
Conclusion: Chronotropic incompetence is prevalent, and associated with a reduced exercise 
capacity in patients with a systemic right ventricle or univentricular circulation. Implantation of 
rate responsive pacemakers may confer functional beneﬁts in these patients.
 
11:30 a.m.
845-7 Long-term Clinical Outcomes in Patients with Isolated 
Congenital Atrio-ventricular Block After Right 
Ventricular Apex Pacing. The Mayo Clinic Experience.
Sandeep Sagar, Arshad Jahangir, Paul A. Friedman, Yongmei Cha, Coburn J. Porter, 
Robert F. Rea, David L. Hayes, Win K. Shen, Mayo Clinic, Rochester, MN
BACKGROUND In selected elderly patients with preexisting heart disease pacing from 
right ventricular apex (RVA) promotes heart failure (HF) presumably due to ventricular 
dys-synchrony. In younger patients with structurally normal heart it is unclear if RVA 
pacing has a detrimental effect on long-term clinical outcome and ventricular function. We 
sought to determine the effect of RVA pacing on overall mortality, incidence of stroke, HF 
and ventricular size and function in patients paced for symptomatic isolated congenital 
AV block (ICAVB). We hypothesize that persistent RVA pacing does not adversely affect 
clinical outcome or ventricular function in this group.
METHODS The study included patients with ICAVB without structural heart disease 
at diagnosis or antibodies associated with cardiomyopathy (Ro or La), who underwent 
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pacemaker implantation (PMI) for symptomatic bradycardia from 1964 to 2004 at the 
Mayo Clinic. The follow up (F/U) information was obtained from a review of medical 
records and PM evaluation. Student t-test was used for statistical analysis.
RESULTS Eighty-six patients (mean age 32±19 years; F/M 57/29) with ICAVB who 
underwent PMI with conventional RVA lead location were identiﬁed. Symptoms (fatigue, 
exercise intolerance, palpitations, dyspnea on exertion or syncope) were alleviated in all 
after PMI. Over a mean F/U of 15±8 years after PMI (longest 39 years) there were nine 
deaths, two related to cardiovascular disease, two patients had stroke and two developed 
new heart failure after myocardial infarction. The mean left ventricular ejection fraction 
increased from 53±11% before PMI to 57±12% on last F/U (n=64; p=0.04) and the 
ventricular end diastolic dimension decreased from 53±8 mm prior to pacing to 52±7 mm 
on last F/U (p =0.04).
CONCLUSION Persistent pacing from conventional RVA position does not adversely affect 
long term clinical outcome and ventricular function in patients with ICAVB and structurally 
normal heart. The effect of RVA pacing and the electrophysiologic-structural-contractile 
interaction may depend upon underlying heart disease, and the patient population; this 
warrants further investigation to optimize pacing methodology in different groups.
11:45 a.m.
845-8 High Complication Rate During Pregnancy In Women 
With Atrial Corrected Complete Transposition Of The 
Great Arteries.
Willem Drenthen, Els Pieper, Martine Ploeg, Adriaan Voors, Jolien Roos-Hesselink, 
Barbara Mulder, Dirk J. van Veldhuisen, on behalf of ZAHARA investigators., University 
Hospital Groningen, Groningen, The Netherlands
Background:Due to advances in surgical care, patients with D-transposition of great 
arteries (D-TGA), nowadays, reach childbearing age. Limited information is available 
regarding the potential complications during pregnancy in these women.
Methods: From the nation-wide Congenital Corvitia (CONCOR) registry, 80 women 
with atrial corrected D-TGA were enrolled. Detailed recordings of each pregnancy were 
obtained after receiving written informed consent. Results were compared with results in 
the general population and available literature.
Results: 69 pregnancies were observed in 28 (73% Mustard) D-TGA patients: 49 
completed pregnancies, 17 spontaneous miscarriages and 3 elective abortions. Analyses 
of the 49 completed pregnancies showed mostly non-cardiac complications: all cause 
hospitalisation (n=20, 41%); premature delivery (n=16, two twins, 31.4%); premature 
labour (n=12, one twin pregnancy, 24.4%); hypertensive disorders (18.4%; preeclampsia 
n=5, gestational hypertension n=4); premature rupture of membranes (n=7, 14.3%) and 
thrombo-embolic complications (n=2). Cardiac complications were also documented: 
clinically signiﬁcant arrhythmia (n=12, 24%), NYHA class deterioration (n=17, 34.7%, 
persisted postpartum n=4) and heart failure (n=2). Forty-seven children (29 boys) were 
born alive. Four children died in utero (7.8%) and 2 died shortly after birth (3.9%). Eleven 
children (21.6%) were small for gestational age. No recurrence of congenital heart 
disease was documented.
Conclusion: In this largest report so far, pregnancy in women with atrial corrected D-TGA 
is not always well tolerated in contrast to current general consensus. Clinically signiﬁcant, 
especially non-cardiac, maternal and foetal complications did occur, and signiﬁcantly more 
often than in the general Dutch population. In counselling patients prior to a pregnancy, 
these results need to be discussed
POSTER SESSION
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1169-237 Myocardial Scaring and Fibrosis in the Failing Single 
Ventricle After Fontan Operation: A New Insight by MRI 
Studies
Gautam K. Singh, Madelyn Stazzone, Pam Woodard, Brian Cupps, Sherry Lassa-
Claxton, Michael Pasque, Glenn Foster, Joseph Billadello, Philip Ludbrook, Michael 
Beardslee, Achiu Ludomirsky, Charles Canter, Washington University School of 
Medicine, St. Louis, MO
Signiﬁcant numbers of patients develop long term progressive ventricular failure following 
Fontan procedure (cavo-pulmonary shunt creation in heart with single ventricle physiology). 
The exact mechanism for this phenomenon is unclear. The purpose of this study was to 
assess if myocardial ﬁbrosis/scaring occurred and contributed to the abnormal regional 
and global contractile mechanics in the single ventricle. 
Methods: Ten pts with single (left) ventricle (median age 20 yrs, 5 M) >10 yrs post-Fontan, 
who were in NYHA class I(3)/II(7) functional status, underwent delayed contrast-enhanced 
magnetic resonances imaging for quantitative assessment of myocardial scarring. Inversion 
time was selected to null normal myocardium. Ventricular function was assessed by cine 
steady-state precession imaging and myocardial strain by myocardial tagging in pts and in 
27 normal subjects (median age 29 yrs, 14 M). Eight slices of images were obtained in short 
axis from ventricular base to apex. Each slice image was divided into 6-segments to assess 
regions of signal abnormality, abnormal wall motion and strain.
Results: Three patterns: diffuse, punctuate and segmental transmural types of scarring 
were seen in 62/480 segments of 9/10 pts, mostly conﬁned to septal and adjoining 
segments representing 4 to 11 % of LV mass/pt. Compared to normal subjects maximal 
shortening strains at midventricular level in pts (-20±3% vs.-15±5%) were signiﬁcantly (p 
< 0.05) decreased, more in segments with (-11±2%) than without (-16±3%) scar. Scar 
affected segments also showed decreased thickening and abnormal wall motion. Single 
ventricle EF (median 42%, range 29% to 59%) was decreased as compared to normal 
population (65±5%). 
Conclusions: Segmental and diffuse myocardial ﬁbrosis/scaring occur at long term in 
Fontan-palliated single ventricles. It may contribute to abnormal contractile mechanism 
resulting in impaired ventricular function and progressive ventricular failure.
1169-238 Sedation for Pediatric Echocardiography: Physiologic 
Responses, Adverse Events, and Risk Factors
Lisa C. Heistein, Claudio Ramaciotti, William A. Scott, Melanie Coursey, Matthew S. 
Lemler, The University of Texas Southwestern Medical Center & Children’s Medical 
Center, Dallas, TX
BACKGROUND: The pediatric response to sedation has not been well documented, nor 
has the population at risk been adequately identiﬁed. Current guidelines for sedation are 
based on insufﬁcient data. We reviewed our experience in a Pediatric Echocardiography 
Laboratory to describe the physiologic responses to sedation, incidence of adverse 
events, and risk factors.
METHODS: We analyzed 1,095 consecutive patients sedated for echocardiography from 
12/01 to 12/03. Fasting times were based on hospital policy with adjustment as clinically 
indicated. Risk scores were assigned using the American Society of Anesthesiologists 
(ASA) Classiﬁcation. Oral chloral hydrate was the primary agent used. Vital signs and 
oxygen saturations were recorded every 5 minutes, and adverse events were noted.
RESULTS: The physiologic responses to sedation included decreases in heart rate 
(median 14%, range 0-68%) and blood pressure (median 23%, range 0-58%), with 
decreases >20% of baseline being common (24% and 58%, respectively) and usually 
well-tolerated. There were no deaths or morbidity. Adverse events included vomiting (n= 
4, 0.4%), apnea (n= 3, 0.3%), airway obstruction (n= 16, 1.5%), hypoxia (n= 66, 6%), 
hypotension with poor perfusion (n= 4, 0.4%), and prolonged sedation (n= 36, 3%). Age 
< 6 months (p< 0.01), cyanotic heart disease (p< 0.01), and hospitalization at the time of 
study (p< 0.02) were predictive of patients with adverse events, whereas ASA score (p= 
0.11), fasting time (p= 0.36), baseline oxygen requirement (p= 0.11), and use of additional 
sedation (p= 0.44) were not predictive. Multiple regression analysis identiﬁed only age < 
6 months as a predictor for adverse events.
CONCLUSION: The observed reactions to pediatric sedation include decrease in heart 
rate and blood pressure without major deleterious effects. Our data indicate that signiﬁcant 
adverse events are uncommon, and that current sedation practices are safe for children 
with known or suspected heart disease. ASA scores and fasting times do not predict risk 
for adverse events. Age < 6 months should be considered during risk assessment for 
sedated echocardiography.
1169-239 Normal Intracardiac and Great Artery Dimensions and 
Ventricular Function in Premature Infants
David W. Brown, Childrens Hospital Boston, Boston, MA
Background: Decisions regarding medical and surgical management of infants with 
congenital heart disease are based primarily upon initial echocardiographic evaluations, 
and normative data for intracardiac structures and ventricular function is vital in guiding 
such decision-making. With advances in neonatal medicine, a growing population of 
preterm infants with congenital heart disease is surviving, and repair early in life is now 
feasible. While normative data for term and older infants are established and clinically 
available, there is little published data regarding such data for premature infants.
Methods: Prospective study of healthy, premature infants in feeding and growing period 
of their hospital course, with normal weight for gestational age, and no signiﬁcant birth 
defects, systemic illness, or structural or functional heart disease.
Results: Forty-two premature infants were enrolled. Median weight was 1.7 kg (range .8 
kg - 3.9 kg), and median BSA 0.14 m2 (range 0.09 - 0.23 m2). Median age at study was 
6 days (range 1 - 56 days). When compared with values predicted by regression in the 
normative data set (z-scores) in term and older infants, structures that were signiﬁcantly 
larger than expected included aortic root (mean z score 0.74) ascending aorta (mean 
0.76), mitral area (mean 0.92), and tricuspid area (0.47). Those signiﬁcantly smaller than 
expected were aortic isthmus (mean -0.62), right pulmonary artery (mean -0.69), left 
pulmonary artery (-0.47), left ventricular (LV) end-diastolic volume (mean-1.26), LV end-
systolic volume (-0.39), and LV ejection fraction (mean -0.85).
Conclusions: Several major intracardiac structures, left ventricular volumes, and left 
ventricular function as measured by ejection fraction in premature infants are signiﬁcantly 
different than regression of normal data from full term and older infants for body surface 
area would predict. Premature infants with congenital heart disease will be better served 
with echocardiographic analysis using a normative data set adjusted for such differences.
1169-240 Initial Experience With 3 Tesla Cardiac MRI Studies 
for Small Infants and Children: The Advantages and 
Problems
Michael Silberbach, Katherine Hopkins, William J. Woodward, Erwin Schwarz, Michael 
Jerosch-Herold, David J. Sahn, Oregon Health & Science University, Portland, OR
Methods: We studied 35 patients with congenital heart disease (CHD) aged 2 days-
19 years, with diagnoses including TOF, VSD, PAPVR aortic area and systemic venous 
anomalies. We used a 3 Tesla Philips system with a phased-array coil with anterior and 
posterior elements, allowing parallel image acquisition in older patients and a 2 element 
ﬂexible surface coil for infants.
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Results: Use of fast ﬁeld echo (FFE) produced artifact-free, high-resolution cine images 
to evaluate anatomy and function and T1-weighted single-shot survey imaging. S/N ratio 
for single-shot T1-weighted imaging of contrast enhancement at 3T was high enough 
for use of parallel acquisition techniques (SENSE) with acceleration factors of 2; echo 
times of approx. 1 ms. High quality angio or perfusion images were obtained without 
appearance of susceptibility artifacts during peak contrast enhancement. 2D and 3D 
gadolinium angiographic sequences were also shortened with parallel acquisitions. In 
small infants, MRI tagging with 6 mm tag-line spacing and 2 mm in-plane resolution 
allowed coverage of the entire cardiac cycle with less tag-line fading than at 1.5 T. FFE 
with steady state free procession (SSFP) was more prone to ﬂow and chemical shift 
(fat/water or air/tissue) artifacts than FFE without SSFP. Image susceptibility artifacts with 
SSFP could only be partially avoided by shimming over the heart, and only standard FFE 
could be useful in infants.
Conclusions: Early experience suggests signiﬁcant advantages for 3T MRI in CHD.
1169-241 Three-Dimensional Echo Quantiﬁcation of Conotruncal 
Areas in Human Fetal Hearts
Aarti Hejmadi Bhat, Christine S. Sahn, Rima S. Bader, Jeanne M. Baker, Laura S. 
Beckwith, Roya Sohaey, David J. Sahn, Oregon Health & Science University, Portland, OR
Background: Discrete aortic and pulmonary arterial roots develop and differentiate 
from a common conotruncus. 3D fetal echocardiography should be able to quantify the 
volumetric commitment of the outﬂow tracts to pulmonary artery (PA) and aorta (Ao) 
during gestation.
Method: Prenatal echocardiograms on normal fetuses referred to the perinatal unit of 
OHSU were done with the GE Voluson 730E 3D system using a 4-8MHz broadband 
curved array with mechanical rotational sweep, acquiring an optimized volume data set. 
Though nongated, image acquisition is rapid enough to virtually freeze the heart in an 
indeterminate cardiac phase. Moving 4D loops were available during the latter part of the 
study. 3D/4D Sonoview® was used for tracing and measurements after navigating in the 
volume to recreate clean short and long axis equivalents of the outﬂow tracts.
Results: Satisfactory studies were possible in 47/61 normal fetuses (15.5-37, mean 24.5 
wks gestation). Conotruncal area including Ao and PA areas in “short axis” was 0.13-2.02 
cm2 (mean 0.63), Ao annulus 0.13-0.91cm (0.4 ± 0.2), PA annulus 0.14-0.92cm (0.5 ± 
0.2). There was good correlation between the “short” and “long” axis estimates of Ao and 
PA annuli (0.82 and 0.85). PA area exceeded Ao area throughout gestation, but the PA/Ao 
area ratio decreased towards term.
Conclusions: Differential volume commitment to each great arterial trunk persists 
throughout gestation, with greater PA dominance in early gestation and a tendency 
toward equalization towards term.
1169-242 Dynamic Insights Into Myocardial Function and Fluid 
Dynamics in Stage 14-18 Chick Embryos From High 
Resolution 60 MHz Real-Time Ultrasound Scanning
David J. Sahn, Morteza Gharib, Kent L. Thornburg, James Pemberton, Jeffrey 
Pentecost, Oregon Health & Science University, Portland, OR, California Institute of 
Technology, Pasadena, CA
Background: The earliest heart movements in the valveless curved embryonic heart tube 
were believed to be poorly synchronized and almost peristaltic.
Methods: We recently performed high resolution 60 MHz, 30 fps ultrasound imaging 
on 14 2-4 days chick embryos, using a VisualSonics VEVO 660 system with 40 micron 
axial/70 micron lateral resolution. Eggs were unroofed and kept in an infrared warmer. A 
mound of gel was built over the embryo location and a curved transducer with a motor 
drive was lowered gently onto the embryo. Rotational motions of the probe allowed 
selective scanning of inﬂow and outﬂow areas.
Results: Dynamic atrio-ventricular coordination was seen even within 6-10 hours of the 
ﬁrst Doppler detectable blood ﬂow motions. In addition, sphincter-like areas deﬁned the 
atrioventricular sulcus and the junction of the muscular conus with a primitive truncus 
arteriosus. The high speckle from nucleated red cells allowed velocity vector tracking 
of ﬂow, and vorticity observations corresponded with steerable spectral pulsed Doppler 
to deﬁne a regurgitant ﬂow vector across the sphincter-like constrictions where valve 
structures would later develop.
Conclusions: These dynamic observations obtainable at this early looping stage of 
embryonic development should provide new insights into heart formation in normal and 
abnormal embryos.
1169-245 Magnetic Resonance Angiography And Gadolinium-
Enhanced Magnetic Resonance Imaging Offer A 
Noninvasive “One Stop” Assessment In Patients With 
Kawasaki Disease
Sophie Mavrogeni, Giorgos Papadopoulos, Marouso Douskou, Savas Kaklis, Alexios 
Giakoumelos, George Varlamis, John Seimenis, Polixeni Nikolaidou, Chryssa Bakoula, 
Evangelos Karanasios, Dimosthenis Cokkinos, Dennis V. Cokkinos, Onassis Cardiac 
Surgery Center, Athens, Greece
Coronary artery abnormalities in Kawasaki disease (KD) develop in about 15-25% of 
young patients, mostly in the form of aneurysms. Although the incidence of pediatric 
disease is low (2-3%), the mortality rate due to myocardial infarction is 22%. Magnetic 
resonance angiography (MRA) can reliably identify coronary aneurysms in affected 
patients. Gadolinium-enhanced MRI (Gd-enMRI) is the gold standard for scar detection 
due to myocardial infarction.
The purpose of this study was: a) to measure the dimensions of coronary artery 
aneurysms using magnetic resonance coronary angiography (MRA) and b) to correlate 
the dimensions of coronary artery aneurysms measured by MRA with the presence of 
myocardial infarction measured by Gd-enMRI in a pediatric population.
Ten patients, aged 1-12 yrs., were studied. The maximal diameter and length of the 
aneurysm was recorded. Coronary MRA was performed using a 1.5 T Philips Intera CV 
MR scanner with two ECG-triggered pulse sequences. The ﬁrst was a three-dimensional 
segmented k-space gradient-echo sequence (TE= 2.1 ms, TR= 7.5 ms, ﬂip angle=30°, eff. 
slice thickness=1.5 mm) employing a T2-weighted preparation prepulse and a frequency 
selective fat-saturation prepulse, with free breathing. Gd-enMRI images were acquired 
15 minutes after the IV injection of 0.2 mmol/kg Gd-DTPA using an inversion recovery 
gradient echo pulse sequence.
In 6 patients discrete aneurysms (AN) of the coronary arteries were identiﬁed, while 
diffuse coronary ectasia (EC) alone was present in the remaining 4 patients. Aneurysm 
diameter ranged from 2 to 9 mm (5.7±2.8), aneurysm length ranged from 4.4 to 16 mm 
(10.1±5.0), and ectasia diameter ranged from 2.5 to 4.6 mm (3.8±0.6). Transmural apical 
scar, due to myocardial infarction, was detected by Gd-enMRI only in one case, while 
small patchy necrosis was identiﬁed in another case. No correlation between aneurysm 
diameter or ectasia length and myocardial infarction was found.
In conclusion, MRA and Gd-enMRI is a reliable diagnostic tool in Kawasaki disease able to 
perform noninvasive coronary artery evaluation and infarct size detection in a single study. 
MRA and Gd-enMRI may prove of great value for the serial follow-up of these patients.
1169-246 Determinants of Aortic Root Growth in Pediatric Marfan 
Subjects
Marieke Bos, Hee Park, Suzanna Vidmar, Jonathan Sterne, Martin Delatycki, Ravi 
Savarirayan, Robert G. Weintraub, Royal Children’s Hospital, Melbourne, Australia
Background: The severity of cardiovascular involvement in Marfan syndrome (MFS) 
determines survival but varies considerably between affected individuals. This study 
examines determinants of aortic root growth in pediatric Marfan subjects.
Methods: The study population comprised all children with Marfan syndrome seen by 
a single clinical genetics service between 1973 and 1991, who had at least one cardiac 
evaluation and echocardiogram prior to 20 years of age. Subjects were divided into 
groups according to whether they had a family history of severe disease (aortic dissection, 
early non-ischemic cardiac death or requirement for aortic root surgery in an affected 
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relative), a family history of mild disease or no family history (sporadic group). Serial 
echocardiographic aortic root measurements were standardized as Z scores, based on 
body surface area. Multilevel models were used to estimate the relationship between 
standardized aortic diameter and age, according to family history grouping, adjusting for 
the use of beta-blocker therapy.
Results: There were 131 Marfan subjects seen during this time with a mean (SD) age 
of 9.46 (5.22) years at ﬁrst evaluation, and a mean duration of follow-up of 8.11 (6.46) 
years. 72 subjects had a positive family history, which was severe in 39 cases. The median 
number of echocardiographic examinations per patient was 5 (range 1-15). 93% of all 
study subjects were treated at some time with a beta-blocker. The mean rate of increase 
in standardized aortic diameter (Z score) was signiﬁcantly higher in the sporadic and 
severe family history groups (0.158/year, 95% CI 0.044 to 0.272 and 0.119/year, 95% CI 
0.043 to 0.195, respectively), compared to the mild family history group (0.001/year, 95% 
CI -0.095 to 0.097).
Conclusions: Among children with Marfan syndrome receiving appropriate therapy, 
those with sporadic disease or a severe family history manifest faster progression of aortic 
root dilatation, compared to those with a family history of mild disease.
ORAL CONTRIBUTIONS
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8:30 a.m.
871-3 Plasma B-Type Natriuretic Peptide In Children With 
Heart Failure
Dana Connolly, Kelley Roots, Sharda McGuire, Michael Artman, New York University 
School of Medicine, New York, NY
BACKGROUND: Plasma B-type natriuretic peptide (BNP) is an accepted marker of heart 
failure in adults and has recently been shown to be useful in the pediatric population. BNP 
has been noted to be of value not only in the diagnosis of heart failure but also to help 
stratify severity of illness and predict clinical outcomes. Evidence in the adult literature 
demonstrates that BNP values of greater than 100 pg/mL are both highly sensitive and 
speciﬁc for the diagnosis of congestive heart failure and cardiac dysfunction. Additionally, 
BNP values of greater than 400 pg/mL are predictive of severe congestive heart failure 
and poor clinical outcomes. The purpose of this study was to explore the clinical outcomes 
of children with BNP levels greater than 100 pg/mL. 
METHODS: Plasma BNP levels were drawn in a series of 50 children, ages 0-17 years 
(5.5 ± 5.86 years) with varying degrees of heart failure as measured by the New York 
University Pediatric Heart Failure Index. Clinical outcomes were assessed 16 weeks after 
BNP levels were drawn. 
RESULTS: All of the children with normal BNP levels were alive at 16 weeks follow-up. 
The mortality rate for children with a BNP of <100 pg/mL (n=31) was 3.2% vs 26.3 % 
with a BNP of >100 pg/mL (n=19; p< 0.02) The mortality rate for children with a BNP 
of <400 pg/mL (n=39) was 5.1% vs 36.4% with a BNP of >400 pg/mL (n=11; p< 0.02) 
Combining both mortality and severe morbidity of heart transplant (M&M), children with a 
BNP of <100 pg/mL had a M&M of 3.2% vs 36.8% with a BNP of >100 pg/mL (p< 0.003). 
In children with a BNP of <400 pg/mL the M&M was 5.1% vs 54.5% with a BNP of >400 
pg/mL (p<0.0007). C
ONCLUSIONS: BNP was shown to have deﬁnite diagnostic value in children with heart 
failure. A BNP level of 100 pg/mL is seemingly, as in adults, suggestive of heart failure 
while a level of greater than 400 pg/mL is suggestive of a critical threshold delineating a 
severe risk of mortality and/or morbidity.
8:45 a.m.
871-4 Longitudinal Assessment of Cardiovascular Exercise 
Performance After Pediatric Heart Transplantation
Julie A. Davis, Michael G. McBride, Brian D. Hanna, Stephen M. Paridon, The Children’s 
Hospital of Philadelphia, Philadelphia, PA
Background: Exercise performance after pediatric heart transplant may be limited 
due to chronotropic incompetence, acute and chronic graft dysfunction, and pulmonary 
and musculoskeletal abnormalities related to peri-operative deconditioning. There are 
no existing data documenting longitudinal exercise performance after pediatric heart 
transplant. The purpose of this study was to assess the longitudinal changes of exercise 
performance following pediatric heart transplant.
Methods: We performed a retrospective analysis of serial exercise tests in patients 
who had undergone pediatric heart transplant between 1996-2003. Measured variables 
included: maximal oxygen consumption (VO2), oxygen pulse (O2P), physical working 
capacity (PWC), peak heart rate (PHR), and ventilatory anaerobic threshold (AT). The 
percent change in VO2 from initial to ﬁnal test for each individual patient was analyzed with 
ANOVA for repeat measurements.
Results: Thirty-seven patients performed 107 exercise tests (median 3; range, 2-5). The 
means (SD) of the % predicted values for the measured variables at initial test were: VO2 
63 (18), PWC 68 (19), PHR 77 (9), AT 61 (12); these remained similarly decreased at 
ﬁnal exercise testing. In the 10 patients (27%) who had initial exercise tests < 24 months 
after transplant, the means (SD) of the % change from initial to ﬁnal tests were: VO2 7 
(11), O2P 19 (24), PWC 16 (21), PHR 4 (7). In the 27 patients (73%) who had initial tests 
>24 months after transplant, the % changes from initial to ﬁnal test were: VO2 -9 (10), O2P 
-10 (17), PWC 6 (19), PHR 0 (9); the VO2 and O2P demonstrated a statistically signiﬁcant 
decline over time (p<0.001).
Conclusions: Exercise performance after pediatric heart transplant is impaired and 
continues to decline over time. Patients initially tested early after transplant tend to show 
improvement in aerobic capacity that may represent recovery from pre-transplant and 
peri-operative deconditioning. Those initially tested later show a statistically signiﬁcant 
decline in aerobic capacity over time that may represent graft dysfunction. These ﬁndings 
suggest exercise testing may be useful as a non-invasive marker of early, insipient graft 
dysfunction.
9:00 a.m.
871-5 The Pediatric Cardiac Quality of Life Inventory:  
A Quality of Life Measure for Children and Adolescents 
with Heart Disease
Bradley S. Marino, David Shera, Judy Shea, Maureen Gallagher, Angela Lee, Whitney 
Stern, Catherine Cho, Lauren Davis, Abigail Aguirre, Elizabeth Tong, David Teitel, 
Kathy Mussatto, Nancy Ghanayem, Marie Gleason, Mark Helfaer, Gil Wernovsky, The 
Children’s Hospital of Philadelphia, Philadelphia, PA
Background: As mortality for pediatric cardiac surgery has decreased, factors affecting 
quality of life (QOL) in survivors has assumed increasing importance. The purpose of this 
project was to create a disease-speciﬁc pediatric cardiac QOL instrument.
Methods: Items for the Pediatric Cardiac Quality of Life Inventory (PCQLI) were created 
from focus groups of patients(child 8-12,adolescent 13-18), parents, and physicians/
nurses. It was distributed to patients/parents at cardiology clinics in 3 university hospitals 
from 2/02-10/03. Factor analysis was performed and items were assigned to mutually 
exclusive groups based on loading values. Item inclusion was based on internal 
consistency (IC) and patterns of correlation.
Results: 293 Child and 438 Adolescent patient-parent pairs were analyzed. 3 factors 
dominated: Impact of Disease (ID), Psychosocial Impact (PI), and Emotional Environment 
(EE). The table summarizes IC and correlation patterns. ID and PI correlated highly with 
each other and with the total score(TS=ID+PI). EE had lower IC, was not correlated with 
ID, PI, or TS and was removed from the ﬁnal forms; resulting in 23 items for the child and 
29 items for the adolescent.
Conclusion: The PCQLI is a disease-speciﬁc instrument to measure QOL in the pediatric 
cardiac population that may be completed by either patient or parent. It’s two subscales 
(ID and PI) have excellent IC, correlate well with each other and with the total score of the 
instrument. Supported by Critical Care Medicine Endowed Chair 
Groups Internal Consistency Correlationwith Other Subscales
Correlation
with TS
ID PI EE ID-PI ID-EE PI-EE ID-Total PI-Total
EE-
Total
Child 0.88 0.78 0.60 0.67 -0.07 -0.04 0.95 0.87 -0.06
Parent of Child 0.89 0.83 0.65 0.70 -0.04 0.07 0.95 0.88 0.01
Adolescent 0.89 0.85 0.84 0.73 -0.11 -0.07 0.95 0.90 -0.10




871-6 Interactive Real-Time Magnetic Resonance-Guided 
Atrial Septal Puncture and Atrial Balloon Septostomy 
are Feasible in Swine
Amish N. Raval, Parag V. Karmarkar, Michael A. Guttman, Cengizhan Ozturk, Ranil 
DeSilva, Ronnier J. Aviles, Elliot R. McVeigh, Ergin Atalar, Robert J. Lederman, National 
Heart Lung and Blood Institute/National Institutes of Health, Bethesda, MD, Johns 
Hopkins University, Baltimore, MD
Atrial septal puncture (ASP) guided by xray ﬂuoroscopy (XRF) is an initial step in many 
procedures, including atrial balloon septostomy (ABS). Compared to XRF, interactive real-
time magnetic resonance imaging (IR-MRI) using modiﬁed interventional devices offers 
superior tissue imaging without ionizing radiation exposure, which is harmful in children. 
We studied whether ASP and ABS are feasible using an IR-MRI platform.
Method: 10 swine underwent IR-MRI guided ASP/ABS . Active ASP needles were inserted 
into 6F/10F dilator and introducer sheaths with passive tip markers. Incrementally sized 
8-18mm balloon catheters inﬂated with 5mM Gd-DTPA were passed over an active wire 
for ABS after successful ASP. Interactive, simultaneous multi-slice, rapid SSFP image 
acquisition/reconstruction was performed.
Results: ASP was successful in 10/10 animals. ASB was successfully achieved in 4/5 
animals. In one case, inadvertent contrast staining of the septum caused image distortion 
and procedure termination. Following ABS, a left to right shunt of 1.5:1 was measured 
invasively. Figures 1a and 1b demonstrate active needle and balloon/active wire across 
the inter-atrial septum.
Conclusion: ASP and ABS are feasible using an IR-MRI interventional platform. Further 
imaging and device development toward future clinical application are warranted.
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871-7 Technical Aspects Of Fetal Aortic Valve Dilation
Audrey C. Marshall, Wayne Tworetzky, Lisa Bergersen, Russell W. Jennings, Louise 
Wilkins-Haug, Carol B. Benson, James E. Lock, Children’s Hospital, Boston, MA, 
Brigham and Women’s Hospital, Boston, MA
Background: Aortic valve dilation in the second trimester fetus with aortic stenosis 
and left ventricular dysfunction is feasible, and may prevent progression to hypoplastic 
left heart syndrome. Technical characteristics of successful valvuloplasty have not been 
described in detail. 
Methods: We reviewed procedures performed on 26 fetuses between 21 and 31 weeks 
gestation. Dilations were carried out with commercially available equipment through a 
19G introducer cannula. A limited laparotomy was performed for uterine exposure in 
12/26 (46%) of cases. 
Results: Technical success was achieved in 20 cases (77%). The diameter of the fetal 
aortic annulus ranged from 2.0 to 4.5mm (median 2.9mm). Neither gestational age nor 
aortic annulus size was associated with technical success. Dilating the valve with balloons 
averaging 110% of the aortic annulus diameter, improved antegrade ﬂow was seen in all 
technically successful cases. Moderate to severe aortic regurgitation (AR) occured in 5 
cases. In each of these cases, AR improved prior to delivery. Use of a novel catheter-
marking system resulted in an average intracardiac procedure time of 7 min 9 seconds. 
Conclusions: Fetal aortic valvuloplasty has been performed with technical success in 20 
of 26 fetuses between 21 and 31 weeks gestational age. A balloon:annulus ratio of 1.1:1 
resulted in improvement in antegrade ﬂow, with at least moderate AR occuring in 25% of 
cases. This AR appears to be well tolerated and can improve over time. These ﬁndings 
suggest that the stenotic fetal aortic valve responds uniquely to balloon valvuloplasty.
 
9:45 a.m.
871-8 Applicability of Live 3D Echocardiography for Fetal 
Cardiac Evaluation
Aarti Hejmadi Bhat, Christine S. Sahn, Roya Sohaey, David J. Sahn, Oregon Health & 
Science University, Portland, OR
Background: We studied adequacy and comprehensiveness of nongated live 3D fetal 
echo in normal fetal hearts.
Methods: Twenty normal fetuses (18-34 weeks gestation) and 14 with asymmetric 4-
chamber views, were studied using a Philips 7500 Live 3D system (3000-element fully 
wired transducer, 2-4 MHz). Images were optimized for axial resolution by adjusting 
bandwidth, pulses per burst and transmit power output. Nongated images could be 
acquired as 3D clips and a simulated ECG allowed acquisition of complete 3D volumes. 
Off-line analysis was performed by 2 trained experts who attempted to derive all the 
essential planes for diagnostic fetal imaging from a single volume.
Results: Navigation within static and moving image planes allowed comprehensive 
visualization of standard and customized views. Pulmonary artery, ductal arch and aortic 
arch views were developed in 27 of the 34 acquisitions, and short-axis unroofed views of the 
semilunar and atrioventricular valves could be obtained in all of the normals and 11 of the 
14 abnormal fetuses. Also, we obtained unique views delineating atrial anatomy, pulmonary 
vein and foramen ovale in the normals and the right/left heart hypoplasia cases.
Conclusions: Our experience demonstrates robust capabilities for this new technology, 
simulating ECGs allowed timed acquisitions of volume sets, thus overcoming the dual 
handicap of fetal ECG gating as well as technical requirements of gated volume capture.
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